Speaker Biographies

I am an executive director and a global clinical lead at Sanofi, a leading global biopharmaceutical company. With almost 15 years of experience as a physician, researcher, and innovator, I bring a unique combination of clinical, scientific, and technological expertise to advance the development and delivery of cutting-edge drugs. My core competencies include clinical development, scientific research, biomedical informatics, telemedicine, critical care, and preventive health. I have led or contributed to multiple clinical trials, publications, and patents, especially in the field of immunology and inflammation. I have also cultivated a global clinical team, forged strategic partnerships, and streamlined clinical outputs. I am passionate about using technology and informatics to improve health outcomes and address healthcare disparities, especially in resource-limited environments. I hope to contribute to a safer, healthier, and more optimistic world that is welcoming for all living beings.

• Bio-IT World: Venture, Innovation & Partnering

Prior to founding Ariana, Mohammad was one of the founders and the Director of Drug Design and IT at RiboTargets, Cambridge, UK.

• Bioinformatics

Dr. Bashir Ahmed is a business oriented, seasoned IT leader in the Pharmaceuticals Industry, currently heading up the Discovery & Development IT organizations at Incyte. He is a scientist and a technology enthusiast who loves to create solutions to challenging problems that make the world a better place every single day. A driver of innovation who pushes the boundaries of technology, challenges the status quo and not afraid to take the unorthodox route to get to the solution. A different kind of visionary leader with multi-disciplinary backgrounds in Science, IT, Management and Business processes who understands the big picture of our industry. Dr. Ahmed holds a BS in Biochemistry, MS in Information Systems Engineering and a PhD in Computer Science. Expediting drug development via innovative Information Technology solution and cross-functional collaboration to save time and to give that savings back to the lives our patients is his mission!

• Digitization of Clinical Development and Clinical Trials

Rob Albert started his career as a medicinal chemist. During that time, he was always tinkering with new technologies, doing proof of concept work, and trying to get other people to adopt the cool new things he was doing. When the chance to do all of that full time (and escape from the lab) he jumped at it and never looked back. Now he focuses on bringing cool new tech and capabilities to the scientists across AZ with an eye on bringing new medicines to patients as quickly as possible.

• Quantum Computing

Nirav leads the Solutions Science team at DNAnexus, working with customers to build solutions for their bioinformatics needs. Nirav obtained his Ph.D. in Genetics and Development at Cornell University, and held postdoctoral and research associate positions at University of North Carolina, Chapel Hill and North Carolina State University. Nirav has diverse experience in bioinformatics, applying his knowledge in R&D and leading Professional Services to help researchers analyze large multi-omic data.

• Data Management

Rachana Ananthakrishnan is Executive Director & Head of Products at the University of Chicago, and has a joint staff appointment at Argonne National Laboratory. In her role at the university, she leads Globus (www.globus.org) department, which delivers research data management services and platform to national and international research institutions. She also serves on the WestGrid Board of Directors, and is a member of the Internet2 InCommon Steering Committee. Her work is focused on research and education field, and she has worked on security and data management solutions on various projects including Earth System Grid (ESG), Biomedical Informatics Research Network (BIRN), and Extreme Science and Engineering Discovery Environment (XSEDE). Prior to that she worked on the Globus Toolkit engineering team and customer engagement teams, leading the efforts in web services and security technologies. Rachana received her MS in Computer Science at Indiana University, Bloomington.

• W8: Instrument-Driven Discovery for the 99%: Modern Infrastructure for Research
• FAIR Data
• Data Management

Experienced Community and Data Manager, leading significant data management initiatives for ELIXIR and serving on the management and steering committees of the ELIXIR-UK node. As a leading editor of RDMkit, the ELIXIR data management toolkit for best practices in life sciences, I’m actively involved with the content creation process and editorial responsibilities, ensuring high-quality of data management content. Co-lead of the ELIXIR Research Data Management (RDM) community, fostering and facilitating the usage of the data management resources to promote the application of FAIR principles. Community lead on the ELIXR Training eSupport System (TeSS), a training platform developed to provide a one-stop shop for trainers and trainees to discover online content. In addition, I’m responsible for the product management and community development of the data management platform, FAIRDOM-SEEK, handling its major users spread across the world. With a Ph.D. in bioinformatics from Japan and extensive experience working in different countries and cultures, I engage with a wide range of stakeholders in the field of life sciences.

• FAIR Data

Experienced in building global, cross-functional data-driven ecosystems for the secure management and execution of analyses leveraging real-world / observational data.

• Digitization of Clinical Development and Clinical Trials

Dave has over 22 years experience selling scientific software with a track record of building successful sales teams and meaningful customer relationships.

• AI for Drug Discovery and Development

Michelle Aponte has spent 29 years in the Pharma and BioTech industries including Schering-Plough, Merck and for the past 6 years at Regeneron. Michelle obtained her BS in Cell and Molecular Biology from Syracuse University and a Master’s in Biotechnology Research from William Paterson University. She started her IT pharmaceutical career at Schering Plough as a Biological Information Specialist working within the Technical Documentation Department. She progressed within the pharma field to become a Laboratory Automation Specialist, implementing robotics into compound management. Later, Michelle transitioned back to the data management world of IT, holding multiple positions, including Data Scientist II, Business/Technical Analyst and Scientific Business Analyst. Currently as a Principal Scientific Business Analyst at Regeneron, Michelle supports multiple Therapeutic Focused Areas, concentrating on acquiring business needs and implementing solutions. Michelle's diligence enables scientists to be more efficient and productive to focus more on the science and the discovery of new Targets. She has excelled in providing these outcomes by utilizing agile methodology along with the newest technologies to assist in the automation of processes and the transformation of data into insights.

• Pharmaceutical R&D Informatics

Akihiko Arakawa is a computational chemist at Chugai Pharmaceutical Co., Ltd. He earned his Ph.D. in structural biology from the University of Tokyo. He specializes in computational chemistry focusing on small/middle-size molecule drug discovery. In addition, he is leading a task team dedicated to exploring the application of quantum computing in their drug discovery research.

• Quantum Computing

Dr. Prabhu Arumugam undertook medical training at St. Bartholomew’s and the Royal London. Prior to starting Pathology training, he completed a PhD at The Barts Cancer Institute on pancreatic pathology. He joined Genomics England in September 2019 and is the Director of Clinical Data and Imaging. He is leading the multimodal programme, focusing on the utility of linking whole genomes to digital pathology and radiology imaging. He is also Genomics England’s Caldicott Guardian.

• AI for Oncology, Precision Medicine, and Health

Nimisha Asthagiri is a Technical Principal and Data Mesh leader at Thoughtworks, a global technology consultancy that integrates strategy, design, and engineering to transform enterprises to modern digital businesses. She leads organization transformations with strategic combinations of design thinking, change management, experimentation, and platform architecture. Most recently, she’s working with Seagen on a digital transformation initiative to accelerate drug discovery. She brings her past experiences as an enterprise architect and technical leader into the digital realm of life sciences.

• Automation, Digital Lab, and Robotics

Deven builds digital transformation solutions for unlocking the power of data. He enables healthcare and life sciences customers to generate insights to fuel innovation to deliver better outcomes. Since his start as a bioinformatics scientist at Whitehead Institute/MIT, Deven has been working directly with clients for the past 20 years to deliver business outcomes addressing strategic opportunities in informatics, discovery research, the lab of the future, clinical trials, real-world evidence, and real-world data.

• Bio-IT World Conference & Expo

Christian Baber, is a chemist by training and holds undergraduate and PhD degrees in computational chemistry with a focus on AI techniques to assess the synthetic accessibility of de novo design compounds. Christian continued this work with a post-doctoral fellowship on the automated design of targeted combinatorial libraries at the Department of Knowledge Engineering, Osaka University, Japan before moving into industry initially as a computational chemist and cheminformatician. Christian has a wide breadth of R&D experience across companies ranging from startups to large pharma and diverse therapeutic areas with a focus on informatics and predictive modeling for drug discovery but has also managed development systems and lab & automation teams including compound management and high-throughput purification. Most recently prior to joining the Pistoia Alliance, after spending the previous 6 years leading Scientific Computing & Informatics and R&D IT at Shire & Takeda, Christian led the global Scientific & Pharmaceutical Data, Informatics and Systems function in Janssen R&D. In addition to his day job, Christian sits on several industry advisory boards, and has been a Director of the Pharmaceutical R&D Information Systems Management Executive (PRISME) forum and chair of the Finance sub-committee of the Pistoia Alliance Board of Directors.

• Modern Data Platforms and Storage Infrastructure

Dr. Banerjee is a Principal Investigator/Scientist at the Institute of Physiology, University-Medicine, Berlin. She is currently appointed as a lecturer at the Freie University Berlin for the MSc Bioinformatics course. She is interested in developing and applying computational methods for analyzing risk associated with chemical compounds. She has worked with machine learning algorithms and is experienced in developing computational models for the prediction of chemical toxicity. She has developed models for the Tox21 challenge platform initiated by the National Institute of Health, USA, and achieved recognition as one of the top 10 winning teams within the Tox21 Challenge 2014 initiative. She developed the toxicity prediction platform ProTox-II, which currently includes 36 freely available computational models for the prediction of chemical toxicity. Dr. Banerjee received her PhD from Humboldt University, Berlin, and studied for a master's in life science informatics at the University of Bonn. Her fields of interest are computer-aided drug design, cheminformatics, and computational toxicology. Her current work is focused on patient-centric drug discovery and applications of theoretical methods integrated with experimental observations in understanding the risk-benefit profile of drugs.

• AI for Drug Discovery and Development
• Generative AI
• AI for Oncology, Precision Medicine, and Health
• Bioinformatics
• Pharmaceutical R&D Informatics

Qixin Bei started his career as a bioinformatician after obtaining his MS degree from UC Berkeley. He has since worked as data engineer and software developer in various biotech and pharmaceutical companies. He joined Genentech in 2006 and has developed many software applications to automate lab workflows in the area of protein production, structure biology and NGS sequencing.

• Automation, Digital Lab, and Robotics

No bio available.

• W7: Unlocking the Power of Data & AI for Drug Discovery

I am the CTO of AION Labs where every 2-3 I am leading the scientific portion of company creation in the Pharma AI space. I am passionate about using data to decipher human disease biology and drive drug discovery and development. My career path took me from big Pharma to biotech to Pharma AI companies. I love the combination of data and biology and most of all to build teams that cover the spectrum of software engineering to data analytics, biology, and medicine. Recently, I switched to a coaching position which is difficult and new but also a lot of fun. Hoping to make a great impact by coaching entrepreneurs and tackling the toughest problems of our industry.

• Generative AI
• Bio-IT World: Venture, Innovation & Partnering

Seasoned entrepreneur. Founded and led three successful tech companies that became world-leaders in their fields, leading revolutions in medicine, gemonics and agriculture.

• Bio-IT World: Venture, Innovation & Partnering

Ari received his Ph.D. in Molecular Biology with a focus on Neuroscience in 2005 from the University of Texas at Austin (UT). His graduate work focused on studying the effects of genetics on addictive behaviors such as alcoholism. His postdoctoral fellowships at the University of California, San Francisco (UCSF) and the Buck Institute for Research on Aging focused on improving our understanding of neurodegenerative diseases of aging (specifically, Parkinson’s and Alzheimers Disease) by utilizing a combination of laboratory science and animal models, as well as bioinformatics and computational biology. Ari is also an expert in Scientific Computing specializing in high performance computing (HPC), high-performance networks, data centers, storage, cloud, general IT infrastructure, and bioinformatics and data analytics. He has been designing, building, and operating scientific computing environments for 27 years and strives to advocate for science and empower researchers to make discoveries from their complex datasets. His ultimate goal is to help create a dynamic enough abstraction of flexible infrastructure from research end-users to enable anyone to analyze and gain knowledge from very complex datasets.

• Cloud Computing
• Data Science and Analytics Technologies
• W2: Data Science in Practice: Embracing the Challenges, Unleashing the Possibilities
• Software Applications and Services
• Modern Data Platforms and Storage Infrastructure
• Data Management

No bio available.

• Data Science and Analytics Technologies

I describe myself as a nonlinear multimodal careerist - I have had 8 so far - from touring rock musician in the 70s to 15 years at IBM - and with several others along the way. My most recent career finds me engaged as a deep tech MC for various quantum events in Silicon Valley, Montreal, Washington, D.C, New York, London and Singapore. I also host the Quantum Tech Pod where I have interviewed over 55 senior execs at leading quantum companies.I am also passionate about helping people reinvent themselves and prepare for the future of work - focusing on career guidance and life design skills. Based on how I successfully navigated my own atypical career path, I have developed a Future Career Toolkit designed to enable learners to be successful when pursuing their own nonlinear, multimodal career path. I conduct workshops titled "How to succeed at jobs that don't exist yet" using the toolkit to excite and empower students at universities as well as in Millennial/GenZ workplaces. With over 14 years of experience as a chief reinvention officer at improvising careers, I help learners of all ages and stages prepare for the 21st century's global borderless workplace.

• Quantum Computing

As a Business Analyst in Clinical Data Flow Transformation team within Takeda’s Data Science Institute, Bimjhana Bishwokarma leads use case metadata curation & validation, and cross-system metadata alignment. She contributes to ensuring study-level metadata integrity, facilitating establishment of R&D Ontology, and supporting metadata-driven approaches in collaboration with Clinical Sciences, Therapeutic Areas, and Information Sciences across R&D. Bimjhana leverages her scientific expertise in Immuno-Oncology, Tissue Engineering, and Translational Science to bridge the gap between complex Clinical Trial data and meaningful insights.

• W3: Semantic Management Technologies and Processes: An Agile Framework to Enable Innovation

Dr. Björsne graduated from the University of Lund and completed his postgraduate studies at Stockholm University, where he obtained his PhD in Medicinal Chemistry. With over 20 years of experience in the pharmaceutical industry, Dr. Björsne has held various managerial positions within the AstraZeneca R&D organization. In 2006, he joined the Strategic Planning & Business Development organization, where he has been leading the Cardiovascular Business Development team. This role involves overseeing the search, evaluation, and transaction of mergers and acquisitions, as well as licensing deals. Since its establishment in 2014, Dr. Björsne has been leading AZ BioVentureHub, a unique initiative that promotes open innovation. This program allows smaller biotech companies and academic groups to collaborate closely with the expertise and capabilities present within a large pharmaceutical company like AstraZeneca. In addition to his industry role, Dr. Björsne serves as an Associate Professor at the Gothenburg University Sahlgrenska Academy. He is also a member of the board at UN Global Compact Sweden, demonstrating his commitment to responsible business practices.

• Bio-IT World: Venture, Innovation & Partnering

I began my journey in the field of Structural Biology, driven by a passion for data-driven decision-making. After transitioning from the wet lab, I ventured into the realm of digital solutions tailored for the life sciences R&D sector. Throughout the past decade, I've collaborated closely with scientists to identify opportunities for digital solutions with an aim to increase R&D efficiency. I joined Roche in 2019, where I've taken up different roles such as Business Analyst, Subject Matter Expert, Project Lead, and Product Owner. Since joining Roche I have supported multiple digital initiatives in various domains, such as Data Automation and Data Management, catering to both Small Molecule and Large Molecule Research.

• Software Applications and Services

2008-2013: Study of Pharmacy (University of Greifswald, Germany) 2014-2017: PhD in pharmaceutical technologies (Additive manufacturing for the manufacturing of oral dosage forms for local drug application, University of Greifswald, Germany) 2017-2018: Postdoc Merck KGaA Scine 2018: Labhead Merck KGaA

• Data Management

Mohan Boggara is currently Digital Transformation Leader working to enable Full Transformation within the CMC Process Development at Sanofi. Prior to this Mohan has spent several years at Amgen as a Scientist/Data Scientist in Drug Product Process Development as well as in Manufacturing & Supply. He has also led major Digital programs. He is a Chemical Engineer with PhD from University of Houston and years of postdoctoral experience from Rensselaer Polytechnic Institute & Rice University

• Automation, Digital Lab, and Robotics

Mayla R. Boguslav, PhD, is a Postdoctoral Fellow in Mathematics at Colorado State University (CSU) with a research focus on natural language processing. At CSU, her focus is on identifying diagnosis codes from SNOMED-CT for veterinary records. In general, she seeks to determine what isn't (yet). She works to uncover our collective scientific questions that are not yet answered by creating taxonomies and using ontologies (controlled vocabularies). Focusing on what science has yet to answer helps researchers locate the role of their ongoing work, clarifies what scientists are saying and what they are not, and rebuilds trust in science. Mayla received the 2023 AMIA Edward H. Shortliffe Doctoral Dissertation Award for her PhD in Computational Biosciences from the University of Colorado Anschutz Medical Campus.

• Knowledge Graphs

Josh has 20 years of software leadership experience and is responsible for the products of Revvity Signals’ research portfolio. Previously, Josh worked at PegaSystems Inc. where he ran and developed an online training application, and at CambridgeSoft. Josh started his career as a scientist at GlaxoSmithKline Pharmaceuticals and has worked alongside scientists ever since. Josh holds a BS in Biology from the MIT and a MS in Technology Education from Harvard University.

• Bio-IT World Conference & Expo

James Bonini, PhD, is an Executive Director in Research and Preclinical Development IT (R&pD-IT) at Regeneron Pharmaceuticals in Tarrytown NY, where he works with colleagues in Research and R&pD-IT to advance digital transformation of Regeneron's Research and Drug Discovery labs. Prior to Regeneron, James worked at Synaptic Pharmaceuticals discovering and cloning novel drug targets, and at Lundbeck Research USA as a scientific database developer and designer. James leverages his lab experience in target discovery, molecular cloning, drug discovery, and his 20+ years of software development and delivery experience to bridge the gap between scientists and technical teams in order to help drive the delivery of innovative data solutions to Research scientists and facilitate the discovery of novel therapeutics.

• Pharmaceutical R&D Informatics

No bio available.

• Modern Data Platforms and Storage Infrastructure

Dr. Christopher Bouton is SVP and Head of AI at Certara, a global leader in biosimulation providing innovative software and services to global pharmaceutical and biotech companies. Dr. Bouton is an author on numerous scientific papers and book chapters and his work has been covered in a wide range of industry news articles. He holds a Ph.D. in Molecular Neurobiology from Johns Hopkins University and a B.A., Magna Cum Laude, from Amherst College.

• Generative AI

Diana is the Associate Director, Data & Digital Strategy in S&T-Biologics Development and Launch leading the organization’s Digital Transformation since October 2021. She joined AbbVie in 2012 in the R&D-Discovery Biologics group focused on antibody and multi-specific protein screening and engineering, leading multiple programs to the cell line development stage. In 2017 she joined Information Research and led a team of IT professionals who supported AbbVie’s Discovery Scientists in Biotherapeutics, Chemistry, Immunology, and Neuroscience. She has a PhD in Molecular Biology from The Scripps Research Institute and Bachelor of Science in Chemistry from The University of Northern Iowa.

• Digital Biopharma

Dr. Laura Boykin is currently a Senior Scientific Consultant at BioTeam and a TED Senior Fellow with 22 years’ experience with genomics and HPC research and solutions for real world problems. Prior to joining BioTeam she was using portable genomics and supercomputing to help smallholder farmers in sub-Saharan Africa control whiteflies and viruses, which have devastated cassava crops. Cassava is a staple food for more than 800 million people globally. Along with scientists in East Africa, she founded the Cassava Virus Action Project to roll out portable DNA sequencing and analysis to farmers. The team also trained local communities in the use of these technologies to tackle future outbreaks. A TED Senior Fellow, Boykin was awarded the Gifted Citizen Prize at the Ciudad de las Ideas Festival in 2017. The prize is given to the best social entrepreneurship project that is having a large-scale impact on humanity’s most pressing issues. She is one of 2019’s Wired 25-innovators who are racing to save us from ourselves.

• Bioinformatics

A scientist by  training and a business development professional by experience. Paul Brake has combined his background und in the life sciences with 20+ years of industry knowledge and expertise to identify emerging business opportunities and drive market development activities into the life sciences ecosystem. He is passionate  about technology solutions that enable healthcare transformation to improve patient outcomes through innovative medical interventions

• Cloud Computing

Barbara Brannetti is Director of data science, characterization, and formulation at the NIBR Biologics Center. The data science team with a broad expertise in the field of protein structure, human genetics, genomics, machine learning, data management and software engineering is leading data science activities in support of the biologics pipeline and technology development.

• Digital Biopharma

Maarten is SVP Bioinformatics and Data Science and heads the bioinformatics departments at Excelra . He is a biotech entrepreneur with over 14 years of experience, having first founded NXT-Dx, a wet lab service provider, and later BISC Global, focused on bioinformatics, statistics, and machine learning consulting. BISC Global expanded to seven locations across Europe and the USA and was acquired by Excelra in 2023, creating an international bioinformatics powerhouse.

• Bioinformatics

I am a senior data scientist at AbbVie working with graph databases of real-world data.

• Digitization of Clinical Development and Clinical Trials

No bio available.

• Knowledge Graphs
• Pharmaceutical R&D Informatics

Rob Brown is Senior Director of Product Marketing at Sapio Sciences. Prior to joining Sapio Sciences he spent eight years at Dotmatics where he held various positions including Head of Global Presales and Head of Product Marketing & Product Management. Earlier in his career he was responsible for product marketing teams for cheminformatics and bioinformatics at Accelrys, SciTegic and MSI. Rob started his career as a postdoc and later research scientist in the Computer Aided Molecular Design department at Abbott Laboratories (now Abbvie). He received his PhD in Cheminformatics from the University of Sheffield, UK.

• Software Applications and Services

Adam Brown empowers drug development teams to extract insights from data using QuartzBio's AI Biomarker Intelligence Platform, working across the SaaS lifecycle: pre-sales, implementation, validation, and ongoing support. He works with data across the precision medicine lifecycle, from early R&D (public 'omics data, literature) to clinical study data (EDC, inventory, exploratory biomarker). Adam is passionate about enterprise-scale data management, focusing on FAIR data, data discovery, and metadata modeling.

• Digitization of Clinical Development and Clinical Trials

No bio available.

• Data Management

Ben Busby works to make biomedical data science a more productive environment to work in for bioinformaticians and biomedical data scientists. At DNAnexus he does this by prototyping both scientific data integration as well as complex compute environments for users of the UKBioBank, as well as many other folks throughout academia, industry and government. Ben also develops prototype software in machine learning, omics, imaging, pharmacogenomics and NLP with his group, as well as in a number of hackathons he runs and participates in around the world. Prior to DNAnexus, Ben consulted for Johns Hopkins University, Ariel Precision Medicine, Deloitte, and NCBI, as well as founding the Bioinformatics and Data Science department at the FAES Graduate School on the NIH campus.

• Bioinformatics
• Pharmaceutical R&D Informatics

Dr. Tiffany J. Callahan is currently a Postdoctoral Research Scientist at IBM Research developing multimodal model generative models to improve our understanding protein hydration thermodynamics. Her PhD thesis leveraged graph representation learning and neural-symbolic reasoning of large-scale biological knowledge graphs in order to develop realistic estimates of human disease mechanisms. Her research interests include computational biophysics, representation learning, and probabilistic mechanistic modeling. She is a lover of all things Semantic Web, an advocate of FAIR transparent science, and an avid supporter of open-source development.

• Knowledge Graphs

Mr. Callow is the Managing Partner of Boston Millennia Partners. Prior to founding Boston Millennia Partners, Mr. Callow co-founded the predecessor fund of BMP in 1982. Before that, he worked as a Senior Consultant at Braxton Associates, an international strategic planning firm that was formed by professionals from Bain & Co. and Boston Consulting Group. He worked with Fortune 100 companies in strategic planning and implementing merger and acquisition strategies. Prior to working in the management consulting business, Mr. Callow worked in sales and marketing for Tymshare, Inc. (McDonnell-Douglas). He was formerly Lead Director and Chair of the governance committee of PAREXEL International Corporation (Formerly NasdaqGS:PRXL), a $2.5 billion revenue clinical trials management company sold on September 29,2017 for $5 billion. He is a lead investor in, or has served as, a Director of a number of other public and private companies, including ILEX Oncology, Inc. (Nasdaq: ILXO), a cancer pharmaceutical company acquired by Genzyme for $1 billion; MedAptus, Inc., a mobile computing provider of clinical, financial and administrative software solutions to the medical community; and COTA Healthcare, Inc., a precision medicine company that stores, tracks and analyzes longitudinal clinical and billing data of oncology patients with the goal of improving outcomes and reducing costs. Other investment responsibilities included Glycofi Inc., (acquired by Merck, NYSE: MRK); HotJobs, Inc. (acquired by Yahoo, NasdaqGS: YHOO); iVillage, Inc. (acquired by NBC Universal, a subsidiary of General Electric, NYSE: GE); and Tektagen, Inc. (acquired by Charles River Laboratories, NYSE: CRL) Mr. Callow is a member of the Advisory Board of the Dartmouth/Tuck Center for Private Equity and Entrepreneurship. He is also a member of the Board of Trustees and member and past Chairman of the Investment Committee at Tufts University and on the Board of Overseers at Tufts University Medical School. Mr. Callow is a National Board member for the Leukemia & Lymphoma Society where he chaired its Therapy Acceleration Program committee. Mr. Callow is a graduate of Tufts University and holds an MBA from the Amos Tuck School at Dartmouth

• Bio-IT World: Venture, Innovation & Partnering

As the co-founder and CTO of Zapata AI, I lead the development and deployment of industrial generative AI software that delivers scientific and computational advantages to enterprises around the world. With over a decade of experience in computer science research and development, I have a strong background in physics, mathematical modeling, and machine learning. My mission is to accelerate the adoption and impact of AI and quantum computing across sectors and society. I have published multiple papers and patents on quantum algorithms, error correction, and machine learning, and I have received prestigious awards for my work in informatics and computer science.

• Quantum Computing

Brent Carlson leads the product development and delivery team for Nurocor. Having spent the first part of his career at IBM, he left in 2000 to co-found LogicLibrary, a software ISV that developed the core technology upon which the Nurocor Digital Asset Repository is based. With over 20 years of enterprise architecture and leadership experience, Brent and his team of talented technologists are extending Nurocor’s reach to the full clinical lifecycle through the suite of Nurocor Clinical Platform applications.

• Digitization of Clinical Development and Clinical Trials

Ishwar Chandramouliswaran is a Program Director and technical lead for the strategy, planning, coordination and oversight of establishing a FAIR data ecosystem at the NIH Office of Director, Office of Data Science Strategy (ODSS).

• FAIR Data

Hareesh Chandrupatla is a member of the Data Engineering & Bioinformatics team in the Data Science & AI department at Genmab. He specializes in developing solutions for translational research with a focus on clinical biomarker data flow and implementation of ML/AI solutions for digital pathology. He holds a Master of Science in Bioinformatics from Saint Joseph's University (formerly University of the Sciences, Philadelphia) and a Bachelor of Science in Asian Studies & Biology from the University of Michigan.

• Digital Biopharma

I founded Clora to organize the world’s life sciences talent. We’re applying technology to accelerate development by enabling companies to access specialized consultants time and cost-effectively. Prior to Clora, I was the head of clinical development at several biopharma companies. I’ve led development activities for 20+ Phase II/III programs that have resulted in 6 product approvals to date. Additionally, I’ve managed business development initiatives in Europe, Asia, and Latin America.

• Bio-IT World: Venture, Innovation & Partnering

I am working as a Data Management and Analytics Lead at Pfizer, I bring 20 years of deep expertise in Global Clinical Supply Chain and Research Data Management. My career trajectory characterizes me as a strategic leader, noted for building and guiding motivated teams towards exceeding organizational objectives. My passion for technology and innovation, coupled with my ability to manage concurrent objectives efficiently, has driven my success in delivering impactful business outcomes.

• Digitization of Clinical Development and Clinical Trials

After a DPhil in Chemistry at the University of Oxford and Post Docs at the University of Manchester and Institute of Cancer Research, Tim gained experience as a medicinal chemist and a molecular modeler at Peptide Therapeutics and Medivir. He joined Cresset in 2002 as Chief Applications Scientist, applying Cresset technology to solve the problems of our clients. He has been instrumental in developing the easy to use scientific software that characterizes a Cresset product today. As Chief Technology Officer Tim is responsible for Cresset’s software solutions for computational and medicinal chemists. His interest in the principles of molecular interactions combined with his commitment to innovative, pertinent and accessible software is evident in every release.

• Pharmaceutical R&D Informatics

A GIGA Society Fellow with over 25 years of experimental and theoretical research experience, Dr. Tom Chittenden is an Honorary Professor of AI in Biomedicine for the Digital Environment Research Institute at Queen Mary University of London (QMUL). Professor Chittenden is the Chief Scientific Officer (CSO) and President of R&D for BioAI Health, where he leads the ongoing development and implementation of the BioAI Health Digital Pathology PREDICT-X Drug Discovery and Development platform.

• Quantum Computing

John Chodacki is Director of the University of California Curation Center (UC3) at California Digital Library (CDL). As UC3 Director, John works across the UC campuses and the broader community to ensure that CDL’s digital curation services meet the emerging needs of the scholarly community - including digital preservation, persistent identifiers, data management, and data publishing. Prior to CDL, John oversaw product development activities at O’Reilly Media, VIZ Media, Zinio, Creative Edge, Safari Books Online, and PLOS. He has served on board and/or steering committees for community organizations including DataCite, FORCE11, ROR (Research Organization Registry), COUNTER, Collaborative Knowledge (Coko) Foundation, Metadata 20/20, Make Data Count, The Carpentries, RDA-US, and OpenCitations. More info: https://orcid.org/0000-0002-7378-2408

• FAIR Data

Dr. Chung is Vice President and Chief Data Office and Director of Data Science Development and Implementation of the Institute for Data Science in Oncology at MD Anderson Cancer Center. She is a clinician-scientist, and associate professor in Radiation Oncology and Diagnostic Imaging with a clinical practice focused on CNS malignancies and a computational imaging lab focused on quantitative imaging and modeling to detect and characterize tumors and toxicities of treatment to enable personalized cancer treatment. Motivated by challenges observed in her own clinical and research pursuits, Dr. Chung has developed and leads institutional efforts to enable quantitative measurements for clinically impactful utilization and interpretation of data through a collaborative team science approach, including the Tumor Measurement Initiative (TMI) at MD Anderson. Internationally, Dr. Chung leads several multidisciplinary efforts to improve the generation and utilization of high-quality, quantitative data to drive research and impact clinical practice, including her role as Vice Chair of the Radiological Society of North America (RSNA) Quantitative Imaging Biomarker Alliance (QIBA), Co-Chair of the Quantitative Imaging for Assessment of Response in Oncology Committee of the International Commission on Radiation Units and Measurements (ICRU) and National Academies of Sciences, Engineering, and Medicine (NASEM)-appointed committee addressing Foundational Research Gaps and Future Directions for Digital Twins. Beyond her clinical, research, and administrative roles, Dr. Chung enjoys serving as an active educator and mentor with a passion to support the growth of diversity, equity, and inclusion in STEM, including her role as Chair of Women in Cancer ( http://www.womenincancer.org/ ), a not-for-profit organization that is committed to advancing cancer care by encouraging the growth, leadership, and connectivity of current and future oncologists, trainees and medical researchers.

• AI for Drug Discovery and Development
• Generative AI
• AI for Oncology, Precision Medicine, and Health
• Bioinformatics
• Cloud Computing
• Data Science and Analytics Technologies
• W6: Biomedical Digital Twins
• Pharmaceutical R&D Informatics
• Software Applications and Services
• Modern Data Platforms and Storage Infrastructure
• Data Management

Adam Churchill is a Product Solutions Manager for CCC, responsible for RightFind XML. Adam offers experience working with customers at every level, understanding the problems they're trying to solve, and working with them to achieve the outcomes they desire. Before joining CCC, he was the Director of Online products at UIE and Director of Customer Contact for Valspar. Adam graduated from Salem State College and lives in Danvers, Massachusetts--almost in the shadow of CCC's corporate headquarters.

• Data Science and Analytics Technologies

Nathan Clark is the founder and CEO of Ganymede, the modern data platform and cloud infrastructure for science. Prior to Ganymede, Nathan was product manager for several of Benchling's data products, including the Insights BI tool and Machine Learning team. Before that, Nathan has a background in machine learning and data systems across financial technology and general technology.

• Data Management

Dr. Alex M. Clark graduated with a Ph.D. in synthetic organometallic chemistry from the University of Auckland. He has more than two decades of experience designing and building tools for computer aided drug discovery. Since 2014 he has been working with Collaborative Drug Discovery to take novel software ideas and build them into prototypes, and guide them to their ultimate destination as part of the CDD Vault product. 

• FAIR Data

James has over a decade of experience in precision oncology, making him integral in GenomOncology's understanding of the field of clinical genomics. James works across GenomOncology’s Precision Oncology Platform (POP).

• AI for Oncology, Precision Medicine, and Health

Zachary works as a Technology Advisor in the Technology Innovation team at AstraZeneca, which he joined as part of the company's Technology Graduate Leadership Program. He received his MSc in Mathematical and Theoretical Physics from the University of Oxford in 2023, where he specialized in quantum computing theory and algorithms.

• Quantum Computing

Dr. Asha S. Collins is a clinical biologist, strategist, and researcher. She is best known for her work in biopharmaceutical operations and currently serves as the general manager of Biobanks for DNAnexus, a venture-backed, cloud-based bioinformatics company. Previously, she was the US country head for country clinical operations at Genentech, a member of the Roche Group. She was responsible for leading the team that executed in-sourced, late-stage, pivotal clinical trials across all US sites for Genentech and Roche. She also led the US Clinical Trial Sourcing business at McKesson Corporation, one of North America’s largest healthcare organizations. In this position, she successfully restructured the multi-hundred-million-dollar business that sources commercial products for research. Within the first year, she established a new organizational operating model, implemented a new technology platform, and standardized processes across a matrix organization that spans the US. Prior to McKesson, Asha was a management consultant focused on creating new operating models for leading biopharmaceutical companies. At Quintiles Consulting, she focused on operational transformation and optimization in clinical development organizations. She generated industry-leading clinical research outsourcing strategies and designed and implemented change management strategies. She also helped define the transformation strategy for three strategic partnerships with biopharmaceutical companies, valued at hundreds of millions of dollars. At Deloitte, Asha led the global process redesign of a clinical development process for the largest pharmaceutical company in the world. In addition to her passion for transforming biopharmaceutical companies, Asha is equally passionate about using her skills and experience to build communities. She is a mentor and angel investor for Backstage Capital, she helps lead community activities with Healthcare Businesswomen’s Association, and she has ongoing work focused on improving healthcare access in East Africa. She earned a PhD in cancer biology from the University of Wisconsin-Madison and a BS in biology from the University of Pittsburgh. When not working on business plans for startups or Fortune 500 companies, you can find Asha out in nature, on a yoga mat, or simply out adventuring. Asha is a Fellow of the fifth class of the Health Innovators Fellowship and a member of the Aspen Global Leadership Network.

• Modern Data Platforms and Storage Infrastructure

Biotech Venture Capital | Captain, United States Air Force (Veteran)

• Bio-IT World: Venture, Innovation & Partnering

Brett rejoined F-Prime Capital in 2018 and focuses on investments in healthcare technology and service companies. Previously, he led finance, partnerships, and business operations at PatientPing, a healthcare technology company providing real-time admission and discharge notifications to coordinate patient care. Previously, Brett worked at Aledade, F-Prime Capital, and McKinsey & Company. Brett holds an M.B.A. from Harvard Business School and a B.S.E. in Biomedical Engineering from Duke University.

• Bio-IT World: Venture, Innovation & Partnering

Jason is the Chief Operating & Innovation Officer. He joined MassBio in September of 2018 as the Vice President of Consortium Operations. In his current role, Jason is responsible for managing business services for our members including; all Edge purchasing and rewards programs, supporting partnering initiatives, sponsor visibility and branding, and MassBioHub sales. Jason received a B.S. in Biology from Emmanuel College. He had worked at BIDMC researching the effects of NSAIDS on ovarian, prostate, and breast cancers and had spent nine years with Thermo Fisher Scientific in various commercial roles. He currently resides on the South Shore with his wife and two children.

• Bio-IT World: Venture, Innovation & Partnering

Executive with 19 years of healthcare and health-tech leadership experience. A serial entrepreneur whose first startup was acquired by a publicly traded company. An investor, speaker, and commercial expert with a proven track record of growing revenue. A hands-on leader with expertise building companies from idea stage to acquisition.

• Generative AI

Samir Courdy is the Senior Vice President, Chief Informatics Officer for City of Hope, where he serves as a key member of the Digital Vertical, and the Senior Leadership Team, and is responsible for designing and building transformative data solutions and incepting innovative digital platforms across City of Hope. In this role, Courdy is charged with solving key challenges of capturing and enhancing the quality of data, and leads a broad range of data improvement initiatives to support City of Hope's Precision Medicine Initiative; clinical, research, data science and real-world data and evidence objectives. Prior to City of Hope, Courdy served as CRIO at the Huntsman Cancer Institute, an NCI designated comprehensive cancer center based at the University of Utah. While there, he oversaw the design and implementation of a next-generation Research Informatics platform serving the many needs of cancer research and precision medicine. Courdy received his bachelor’s in computer science and executive MBA both from the University of Utah.

• AI for Oncology, Precision Medicine, and Health

Richard Cramer is the Chief Strategist for Healthcare & Life Sciences at Informatica. He is a 25-year veteran of the healthcare industry and held senior technology leadership roles at the University of Pennsylvania Health System and UMass Memorial Health Care. He is a frequent speaker on healthcare analytics and data management strategies.

• Cloud Computing

I am a software engineer by training with a passion for solving complex issues related to manufacturing and research. I love to bring client requirements to life through software and see the impact of their ideas on their fields. I have conducted multiple software projects over the last 10 years ranging from blank sheet customer software to complete validated IT landscape integration projects. My current focus in Roche is around integrating and developing various application and data sources to help our scientist deliver medicine quicker to patients.

• Pharmaceutical R&D Informatics
• W5: Digitalization of Pharma R&D-Master the Marathon

Cindy Crowninshield, RDN, LDN, HHC has over 25 years of experience as an expert program developer and project leader for global business and scientific conferences. Since joining Cambridge Innovation Institute (CII) in 2005, she has been responsible for overseeing a portfolio of large-scale events. She started working on the Bio-IT World Conference & Expo in 2007 and is still the lead producer. Cindy has created and delivered over 200 highly-focused executive-level conferences and events attracting international audiences of up to 18,000 delegates, both for CII and other organizations. In addition to her conference work, Cindy has two other parallel careers - 1) Licensed Registered Dietitian and Functional Nutrition Educator in private practice, and 2) Adjunct Instructor, Department of Clinical Research and Leadership at The George Washington University School of Medicine and Health Sciences. She has a BS in Business Management from Fitchburg State University, completed graduate study in nutrition science at Boston University Sargent College, and completed certification with the Institute for Integrative Nutrition & Holistic Health. In 2011, she was one of the founding members of the Women in Bio - Greater Boston Chapter.

• AI for Drug Discovery and Development
• Generative AI
• AI for Oncology, Precision Medicine, and Health
• Bioinformatics
• Cloud Computing
• Knowledge Graphs
• Data Science and Analytics Technologies
• FAIR Data
• Quantum Computing
• Pharmaceutical R&D Informatics
• Software Applications and Services
• Modern Data Platforms and Storage Infrastructure
• Data Management
• Automation, Digital Lab, and Robotics
• Digital Biopharma
• Digitization of Clinical Development and Clinical Trials

Jerry Curran is the Director of Academic Research at Abiomed. He has been with Abiomed since 2015. He oversees a team of PhD and MD level researchers and associated staff to conduct proof of concept clinical and preclinical research programs aligned with the strategic focus of the company. Jerry oversees the design and execution of IDE-enabling research programs aimed at supporting future regulatory submissions, and establishing and maintaining investigator-initiated clinical trials. A specific focus of his group at Abiomed is the development of digitized real-world data capture systems that will simplify clinical trial data entry and execution. Jerry holds a PhD from Rush University (Chicago) in molecular biophysics and physiology.

• Digitization of Clinical Development and Clinical Trials

John Damask joined Flagship Pioneering in May 2019 as Vice President of Data & Systems Engineering. John brings over 20 years of experience delivering value to organizations of all sizes through software and informatics solutions. At Flagship, John is responsible for providing strategic leadership around the use of data and technology across its portfolio of bioplatform companies. This includes digital strategy, cloud and scientific computing, architecture, engineering, data management, automated operations, governance, and bioinformatics.

• Generative AI
• Modern Data Platforms and Storage Infrastructure

• Bio-IT World: Venture, Innovation & Partnering

David Deng received his bachelor degree in Organic Chemistry from Peking University, and his Ph.D. in Computational Chemistry from RPI (Rensselaer Polytechnic Institute). After finishing his postdoc in the Cheminformatics group at Roche in Nutley NJ, he joined ChemAxon as an Application Scientist, working closely with the development teams and the clients. In 2015, he joined Scilligence as the Director of Software Development, leading the development team and technical support team to improve and deploy Scilligence informatics solutions. In 2020, he came back to Pharma and joined Takeda as Scientific Informatics Technology Lead. He has been leading a cross-platform team to deploy the very first global ELN (Dotmatics) to 2,000 Takeda scientists and decommission more than 10 legacy ELN systems.

• Software Applications and Services

Vinay C. Desai is a Sr. Director, Regeneron IT and supports the Regeneron Research and Pre-Clinical Development Scientific area’s information technology needs. He is an Experienced IT/Pharmaceutical professional with proven global results-driven career in science and information technology in the pharmaceutical industry. His team supports scientific instrumentation and scientific instrument data management needs at scale in collaboration with other Regeneron IT colleagues. Prior to working at Regeneron, he has experience working as a consultant in the BioPharmaceutical industry and also held various leadership roles supporting scientific technology at Allergan, Merck & GE Healthcare. His academic credentials include a Ph.D. in Pharmaceutical Sciences through the Univ. of Oklahoma Health Sciences Center, an MBA from Penn State University and he is a certified Six Sigma Black Belt.

• FAIR Data
• Automation, Digital Lab, and Robotics

Aniket Deshpande is senior GTM specialist for HPC in Healthcare Lifesciences at AWS. Aniket has more than a decade of experience in the biopharma and clinical informatics space, where he has developed and commercialized clinical-grade software solutions and services for genomics, molecular diagnostics, and translational research. Prior to AWS, Aniket has worked in various technical roles at DNAnexus, Qiagen, Knome, Pacific Biosciences and Novartis.

• AI for Drug Discovery and Development

Lena is a Principal of Technology Solutions in the Data & Analytics Practice at EPAM. She is a data science and bioinformatics expert with extensive experience in delivering value to her clients through effective data governance, data analysis, and predictive AI, particularly within the R&D and Healthcare sectors. With proficiency in FAIR principles, she actively contributes to pre-competitive consortia such as the Pistoia Alliance, ensuring that her clients are equipped with awareness of industry standards. Lena holds a PhD in Bioinformatics from Universidade Nova de Lisboa (2011) and an MS in Biology from Universidade de Lisboa (2004). She has received 9 awards, including the Elsevier Silver Coin and the NASA Space Apps Challenge winner. Lena has authored over 50 peer-reviewed publications in healthcare and life sciences, accumulating more than 1000 citations. Additionally, she has a patent to her name and has delivered 5 keynote addresses.

• Pharmaceutical R&D Informatics

Dr. Murthy Devarakonda is an AI innovator, a research leader, and an amateur technology futurist, working on applying AI to drug discovery. His expertise is in AI models for NLP, knowledge graphs, and bio sequences. Prior to joining Novartis, he was a Distinguished Scientist at IBM Research where he led the initiative on applying IBM Watson to clinical data, and he was a senior faculty in Biomedical Informatics at Arizona State University. He is a Fellow of IEEE and AMIA (Americal Medical Informatics Association), and a Distinguished Member of ACM. He received Ph.D. in computer science from University of Illinois at Urbana-Champaign. He is a prolific author of peer-reviewed papers and book chapters and received over 60 patents.

• Generative AI

Dr. Jaspreet Kaur Dhanjal is an Assistant professor in the Department of Computational Biology at the Indraprastha Institute of Information Technology, Delhi, India. Before joining IIIT-Delhi in 2021, she received her PhD degree from Indian Institute of Technology Delhi (IITD) in 2019, and then worked as a Postdoctoral Fellow at the National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba Japan. Her research interests have been at the interface of computation, cellular and molecular biology. In particular, she is interested in studying disease pathologies in the context of personalized medicine, with special focus on cancer and rare diseases. She is also interested in exploring the mechanism of action of bioactive compounds from natural sources. She was awarded with the Har Gobind Khorana-Innovative Young Biotechnologist award by the Department of Biotechnology, Govt. of India. She has co-authored over 50 papers in peer-reviewed international journals, and has also contributed in multiple book chapters.

• AI for Oncology, Precision Medicine, and Health
• Bioinformatics

I currently serve as Chief Science Officer at Velsera where I oversee the Scientific Program Management and Researcher Education & Adoption teams. I am also responsible for the scientific strategy of the company spanning government, non-profit, biotech, pharma, and diagnostic sectors. I am a natural consensus builder who leads by prioritizing listening and building trust to drive progress. Balancing consistent optimism, vision, and inclusivity while serving as a steading force has been crucial to motivate strong performance of the teams I’ve led. Often leading without direct authority, fostering strong internal and external relationships has been critical to driving success. Multidisciplinary academic research followed by developing data ecosystems for academic, biopharma, and government partners has sharpened my abilities as a natural translator. I excel at distilling complex technical and scientific concepts for diverse audiences - from high-school to the corporate C-Suite.

• FAIR Data

Erin Diel is the Head of Product for Glencoe Software. She has worked with imaging data directly and in the context of educating and supporting users of imaging data for over ten years. She has worked with Glencoe Software for four years, in particular supporting large academic institutions and pharmaceutical companies in their management of imaging data in computational pathology and screening use cases.

• Data Science and Analytics Technologies

Zainab is a Senior Director of Product at ConcertAI within Digital Trial Solutions, working on developing data and generative AI driven products. She has spent her career working at the intersection of life sciences, data and software. Zainab completed her PhD in Chemical Biology from Harvard in Dr. Nathanael Gray’s lab at Dana Farber, developing small molecule covalent kinase inhibitors and degraders for oncology targets. She earned her Bachelor’s Degrees in both Biology and Applied Math and Statistics from Johns Hopkins University.

• Digitization of Clinical Development and Clinical Trials

Dr. Leela Dodda is the Director of Computational Chemistry at Nimbus Therapeutics. At Nimbus, Dr. Dodda's role entails supporting the discovery pipeline and developing machine-learning models for ADMET predictions. In particular, he is interested in leveraging the graph neural network’s ability to do multi-task learning and transfer learning from Quantum Mechanical data to create models that are not data-hungry. Before Nimbus, he worked at Vant AI and Silicon Therapeutics. Dr. Dodda completed his Ph.D. in Computational Chemistry from Yale University, working with Prof. William Jorgensen on novel methodologies for structure-based drug discovery.

• AI for Drug Discovery and Development

Ms. Dolcetti boasts over 15 years of multifaceted expertise in Global Health Tech, Digital Innovation, and Artificial Intelligence, with a background spanning startups, Fortune 500 companies, academia, and management consulting, including a tenure at Boston Consulting Group. Specializing in life sciences, she excels in corporate strategy, private equity/venture capital, partnerships, and commercialization, showcasing a knack for successful product launches. Her subject matter expertise spans precision medicine, diagnostics, genomics, oncology, and the integration of AI, informatics, data analytics, cloud infrastructure, and SaaS solutions. A seasoned professional in navigating the convergence of healthcare and technology, Sara brings strategic acumen to the evolving landscape of digital health and medical devices. Continuously staying abreast of industry trends, she is a driving force committed to advancing healthcare through innovative technological solutions.

• Quantum Computing

Driven by my intrinsic curiosity and need to discover, I specialised in the use of machine learning and quantum machine learning techniques to tackle relevant problems in today's society. This path led me to recently obtain the prestigious PhD fellowship from La Caixa Foundation, with which I have made publications about quantum machine learning applications and quantum algorithms designs. My life goal is to create an impact on society by using my mathematical skills and knowledge of the physical world.

• Quantum Computing

No bio available.

• Modern Data Platforms and Storage Infrastructure

No bio available.

• Knowledge Graphs

Dr. David Drake has over 20 years’ experience in Drug Discovery IT, including roles as Early Science Enterprise Architect, Enterprise Data Architect, and currently Drug Discovery Capability Lead at AstraZeneca UK. David provides strategic thought-leadership and domain expertise on the future direction of the IT platforms & applications supporting Early Science, working closely with senior science leaders to ensure alignment with R&D’s direction and focus.

• Digital Biopharma

Seth Earley is an expert with 20+ years experience in knowledge strategy, information architecture, search-based applications and information findability solutions. He's the author of the award-winning book, The AI Powered Enterprise, and is a sought after speaker, author, and influencer. Recognized by Thinkers 360 as one of the Top 50 Global Thought Leaders and Influencers on Artificial Intelligence 2022.

• Knowledge Graphs

Sheila Elz grew up in Michigan, USA, and now lives in Germany. After a career as concert pianist, she acquired a BSc in Nutritional Science and an MSc in Toxicology, specializing in biochemistry and statistical analysis. Sheila brings her regulatory perspective to her current job as Master Data Manager at Bayer AG Pharmaceutical R&D. Her primary focus is on cross-functional and global master- and reference-data management. Additionally, she is co-leading two International Organization for Standardization (ISO) teams of experts in the drafting of guidance on indications terminology harmonization and on IDMP Ontology for the ISO Identification of Medicinal Products (IDMP) standards, and she is co-leading the Pistoia Alliance IDMP Ontology.

• Modern Data Platforms and Storage Infrastructure

Michael Farnum works for the Novartis Institutes for Biomedical Research on strategies to bring data together to solve impactful problems in drug discovery. In the past, he driven data integration efforts for Covance, Janssen, and 3-Dimensional Pharmaceuticals.

• Digitization of Clinical Development and Clinical Trials

Ralf Felsner started his career at the lab bench focusing on mAb generation and characterization, tissue and bone regeneration therapeutics, and assay development and validation. Ralf's transition to business development was propelled by his passion for leveraging technology to drive scientific progress. As a Director at Collaborative Drug Discovery (CDD), he channels his expertise into fostering strategic partnerships, always with the aim of helping companies to speed up research to develop effective treatments.

• Pharmaceutical R&D Informatics

Evan Floden is the CEO and co-founder of Seqera where the team has spent the last decade building Nextflow and the modern biotech stack. By providing scientists with modern software development tools such as containers, cloud, and git - Seqera is making scientific data analysis accessible at any scale. Evan is a strong advocate for open science through Seqera projects such as MultiQC and Wave containers.

• Bioinformatics

No bio available.

• Cloud Computing

Julia Fox is part of the Clinical Data Flow Transformation team in Takeda’s Data Science Institute, where she leads multiple efforts to broadly define and support metadata-driven approaches in Clinical Trial & Data management, in close collaboration with Clinical Sciences, Therapeutic Areas, Information Sciences and across R&D. Julia has a background in developmental genetics, genomics and drug discovery informatics specializing in scientific semantics, data curation and annotation. She will share approaches to developing aligned common data models for institutionally shared metadata object definitions supported by scientific and clinical ontologies. Harmonized metadata and richly annotated data sets accelerate analysis and innovation.

• W3: Semantic Management Technologies and Processes: An Agile Framework to Enable Innovation
• Digitization of Clinical Development and Clinical Trials

Wouter is a curious consultant with a background in both Computer Science and Organisational Change. He has extensive experience with large implementations of data programs in complex networks of public and private organizations within healthcare. For the past several years, he has been working on the research and development of FAIR and implementing FAIR within programs. His goal is to ensure that data within healthcare is available to a wide range of stakeholders and is machine-actionable. This, in turn, will significantly increase the value of existing and emerging capabilities in the field of data science, ultimately resulting in better prevention and healthcare for people. When not working, Wouter loves to travel with his family or spend time reading a book or two.

• AI for Drug Discovery and Development

Daniel Franke is an Investment Director in the Technology team at M Ventures. Prior to joining the team in 2018, Daniel obtained his Bachelor’s and Master’s in Chemistry at RWTH Aachen University before moving on to the Massachusetts Institute of Technology for his Ph.D. studies. At MIT, Daniel developed semiconductors for display technologies and advanced biomedical imaging applications, leading to a patented biomedical imaging platform on basis of shortwave infrared light. Daniel is based in Boston.

• Bio-IT World: Venture, Innovation & Partnering

Dr. Michael A. Freitas is a Professor in the Department of Cancer Biology and Genetics at the Ohio State University (OSU) Wexner Medical Center. His expertise is in mass spectrometry, bioinformatics, and data science. He plays a leading role in bioinformatics education at OSU. In addition, Freitas co-founded MassMatrix Inc., a software company developing data analysis solutions for biopharma. As MassMatrix’s Chief Scientific Officer, he guides the creation of novel bioinformatics software solutions to aid biopharmaceutical advancements. Dr. Freitas has worked in the field of mass spectrometry and proteomics for over 30 years and spent recent years developing and improving mass spectrometry and bioinformatic methods for his research in cancer proteomics and chromatin biology. After earning his PhD at Kansas State University, Mike undertook postdoctoral research at the National High Magnetic Field Laboratory. He received the Camille and Henry Dreyfus New Faculty Award, an American Society for Mass Spectrometry Research Award, and was nominated an OSU Innovator of the Year. He also serves as Co-director of the OSU Comprehensive Cancer Center’s Proteomics Shared Resource and advisor to the OSU Campus Chemical Instrument Center’s Mass Spectrometry and Proteomics Facility.

• Data Science and Analytics Technologies

No bio available.

• W5: Digitalization of Pharma R&D-Master the Marathon

Professor Dmitrij Frishman received a M.S. in Biomedical Electronics from the Saint Petersburg Electrotechnical University and a Ph.D. in Biochemistry from the Russian Academy of Sciences. He is a Professor for Bioinformatics at the Technical University of Munich. Prof. Frishman's current research interests focus on protein structure prediction, analysis of protein interactions, cancer bioinformatics, mRNA evolution, and virus bioinformatics.

• Pharmaceutical R&D Informatics

Dr. Gaenzler holds a Doctorate in Molecular Biology from the University of Heidelberg and contributed to the development of the first HPV vaccines during his time at the German Cancer Center. Outside of academia Dr.Gaenzler served as Senior Consultant and PreSales Manager at TIBCO Spotfire, and as Senior Principal Product Marketing Manager Biology at PerkinElmer Informatics. Currently, Dr.Gaenzler brings his expertise to ZONTAL as the Director of PreSales and Product Marketing.

• Data Management

Results-driven R&D Informatics Program Lead/Product Owner building digital and data-driven business outcomes by providing long and short-term IT strategies. Experience in establishing data-centric culture and community, building fully automated instrument data integration capability by establishing information and data model aligning with FAIR data principles and transformations to run advanced analytics and data-driven insights to select fast and the best drug candidate for Pharma R&D. Accomplished gene sequence analysis for GWA and CNV using different Bioinformatics tools. Built Artificial Neural Networks by using Machine Learning Algorithm for Ribosome Binding Site (RBS) search. Excellent analytical, problem-solving, and leadership skills, coupled with outstanding communication and interpersonal skills with expertise in managing global matrixed teams, and relationship building with senior leaders of the organization by delivering clear and effective executive-level communications and updates.

• Digital Biopharma

Chelsea Gallagher is the Senior Director of Drug Development Innovation and Digital Health Analytics. She is a thought leader in clinical design innovation and has spent the past few years building analytics solutions to optimize trial design for patients, investigators and sponsors, resulting in sustained tens of millions of dollars in cost avoidance per year . Her recent work has shifted focus to automation and optimized process, achieving timeline acceleration and reduced resource burden. With over ten years of experience in analytics across multiple functions, Chelsea has leveraged her expertise in design thinking, change management, and analytics techniques to solve challenging problems at BMS. She works with stakeholders to identify root cause pain points, recognize synergies across functions, and design solutions that meet future and current business needs

• Digitization of Clinical Development and Clinical Trials

Pratik is a Manager at ZS Associates, based out of New Jersey. He is passionate about enabling data- and technology-led transformations for his clients. He has been working on tech solutions implementation for the pharmaceutical industry for over a decade. He is explicitly focused on the research part of R&D for the last 5 years and has worked on building innovative tech solutions for molecular discovery, pre-clinical research, translational research, clinical pharmacology, and other research areas. From data warehouse to data lake world to the latest data mesh implementations, advanced analytics, to machine learning, Pratik has hands-on expertise in a wide variety of areas. He is known for generating quick measurable outcomes while enabling long-term success.

• Automation, Digital Lab, and Robotics

Ophelia Gao is the Senior Manager of Business Analytics at the Global Development Office in Takeda Pharmaceuticals. With a background in Epidemiology and Biomedical Engineering, Ophelia has a unique perspective on the intersection of healthcare and technology. Prior to joining Takeda, she worked on Clinical Analytics Strategies at Anthem and a healthcare AI startup, AllazoHealth, based in New York City. Ophelia is passionate about leveraging data and technology to improve patient outcomes.

• Digitization of Clinical Development and Clinical Trials

Yan Ge is the Director of Data Analytics in the Data Sciences Institute at Takeda Pharmaceuticals. An industry veteran with over 20 years of experience in the Life Sciences and Healthcare, Yan has built up Analytics and Data Science capabilities at three different companies including Takeda. His focus in Takeda are research including discovery, translational and real-world plus applications of AI/ML to address R&D challenges. Before Takeda, Yan served in data analytics leadership roles in Ascensia Diabetes, Telcare, Deloitte Consulting, Medidata and IBM among others. Yan holds multiple graduate degrees in Statistics, Molecular Biosciences and MBA with his BSc in Applied Chemistry from Peking University, China.

• Digitization of Clinical Development and Clinical Trials

Mike Georgiadis is a Scientific Business Analyst at Regeneron. He excels in building innovative, creative (and often unusual) solutions to complex problems using a data-driven, rapid prototyping approach. At Regeneron, his focus is on data connectivity and visualization, management of lab data, and on helping labs make their processes more efficient. Mike’s ability to understand diverse audiences and their unique contexts is evident in his wide-ranging impactful solutions he has helped to deliver, some of which will be presented at Bio IT World 2024. Prior to Regeneron, Mike worked as an Analyst on a Business Intelligence team at Thermo Fisher Scientific, where he honed his data visualization skillset. Previously, Mike was a Scientist at Thermo Fisher Scientific, where he designed novel scientific instrumentation on a rapid prototyping team. Mike’s educational background is in Chemical Engineering, and he also holds a MBA.

• FAIR Data
• Automation, Digital Lab, and Robotics

Karthik Ghantasala, is Director of Cloud Architecture and Strategy at Vertex Pharmaceuticals. His expertise is in Cloud Architecture, Security and System Design.

• Cloud Computing

Molly is an Origination Partner at Flagship Pioneering, working as part of a venture-creation team to found and grow companies at the intersection of biology and machine learning. Molly serves as co-founder & chief strategy and chief innovation officer of Generate:Biomedicines, a Flagship Pioneering company, where she has served many roles from R&D to corporate strategy, platform and data strategy, and launching an innovation group, called G:Labs that explores novel applications of The Generate Platform. Through her role in Flagship Labs, Molly has contributed to the launch and growth of Tessera Therapeutics and Cobalt Biomedicines, which was merged into Sana Biotechnology. Molly’s work has resulted in multiple pending patents and publications, including articles in Science and Nature. Molly was honored in 2020 in Endpoints News' 20 under 40 list in biopharma and in 2021 in Business Insiders’ list of 12 young serial entrepreneurs building the next generation of biotech startups. Molly received a PhD in computational and systems biology from Washington University in Saint Louis in the Center for Genome Sciences, with the support of a National Science Foundation Graduate Research Fellowship. At Washington University, Molly collaborated with St. Louis Children's Hospital to study the effects of early-life interventions on development of the preterm infant gut microbiome and health outcomes.

• Bio-IT World: Venture, Innovation & Partnering

Linda Goodman is a co-founder and the CTO at Fauna Bio, a San Francisco Bay Area startup that utilizes natural animal models of disease resistance and ML approaches to design therapies for human diseases of high unmet need. Linda has extensive experience in human medical genetics and mammalian comparative genomics. She was a postdoctoral scholar at Stanford University and the Broad Institute, and she holds a PhD from Harvard University and an MPhil in Computational Biology from Cambridge University.

• AI for Drug Discovery and Development

William Goodman is the Senior Director of Product Management at Thermo Fisher Scientific, bringing a wealth of knowledge and expertise to his role as an experienced life sciences industry professional. Bill has held leadership roles at renowned organizations, including Agilent and PerkinElmer. With his background in product management, he has proven his ability to drive innovation, develop and launch new products, and successfully navigate the dynamic landscape of the informatics market. 

• Modern Data Platforms and Storage Infrastructure

Harini Gopalakrishnan is the Global Field CTO for Life Sciences for Snowflake, based out of New York and works to contextualize Snowflake and partner solutions for pharma/biotech customers. She has 20 + years experience and worked in leadership roles across both tech and life sciences mainly focusing on RWE & Drug Discovery solutions.Her prior stints include AWS, Sanofi, Syneos and Cognizant. She has a Master’s in Bioinformatics and is passionate about technology and innovations they drive in life sciences.

• Modern Data Platforms and Storage Infrastructure

Julie Gorenstein is part of the Clinical Data Systems & Architecture team in the Data Science Institute at Takeda, where she co-leads efforts to streamline data processes and technological pipeline for sample-based, imaging and device clinical data. After building her analytical toolkit while obtaining degrees in Biomedical Engineering and Bioinformatics, Julie focused on target evaluation and molecule identification within oncology R&D, followed by tenure in scientific software development & consulting. She hopes to share her learnings regarding necessity of semantic management of clinical metadata to enable its use in AI/ML.

• W3: Semantic Management Technologies and Processes: An Agile Framework to Enable Innovation
• Digitization of Clinical Development and Clinical Trials

Luba Greenwood is a distinguished executive, investor, and company builder with over 20 years of experience in the healthcare and tech sectors. Luba has served as the Chief Executive Officer and Chair of the Board of Kojin Therapeutics, a leader in ferroptosis. She currently serves as the Managing Partner of the Dana Farber Cancer Institute Venture Fund, Binney Street Capital (BSC), which she has founded, investing and building companies across therapeutics, diagnostics, and digital sectors. She has also served as a lecturer at Harvard University in the School of Engineering and Applied Sciences. Ms. Greenwood has extensive board experience globally and serves on public and private boards, across multiple industries, including healthcare and tech, and has successfully contributed to the growth and profitability of numerous organizations, bringing her operational, industry, and financing expertise. She has a proven track record of building world-class teams and companies, building SABs with renown scientists and industry leaders, driving digital transformation and artificial intelligence initiatives, guiding companies through mergers & acquisitions, complex business development transactions, financing, and organizational change and scaling. With a strong understanding of board dynamics and corporate governance best practices, and as a former lawyer, she has also guided organizations through compliance, activist actions, and human resources challenges. She has served as Chair of the board as well as on the Compensation, Audit, and Nomination committees of a number of companies including In8Bio (INAB), BenchSci, Swiss-based Stalicla, Abcam (Abcam), where she has spearheaded the sale to Danaher (DHR), and non-profit, Massachusetts Biotechnology Council (MassBio). Ms. Greenwood has previously served in leadership roles at Google Life Sciences (Verily) and as Vice President of Global Business Development and Mergers & Acquisitions at Roche, where she also led diagnostics BD and established and led the East Coast Innovation Hub. Luba has led $5B+ in M&A, BD deals, and investments across multiple therapeutic areas, diagnostics, life sciences, and tech sectors globally. She has also co-founded and advised biotech and digital health companies in the immunotherapy, AI/ML, women's health, and microbiome space, including Luca Biologics. Her invaluable contributions to the healthcare industry have earned her recognition as a thought leader and a trusted advisor to CEOs of leading academic centers worldwide, including the Dana Farber Institute and Wyss Center for Bio and Neuroengineering in Geneva. She is a Thought Leader for the New England Journal of Medicine (NEJM) Catalyst and serves on Investor Committee for the National Cancer Institute. With a background as a former lawyer at Wilmer Cutler Pickering Hale and Dorr and expertise in regulatory, policy, and intellectual property matters, Ms. Greenwood brings a unique perspective to the table. Her commitment to advocating for women in science and technology has garnered several awards and honors, including the Science Club for Girls Catalyst Award.

• Bio-IT World: Venture, Innovation & Partnering

Sofia is an investor in the Cambridge office, where she focuses on healthcare and biotech. Sofia began her career as a consultant at Bain and Company, where she worked on strategy, operations, and due diligence projects across healthcare and technology. Prior to joining Bessemer, she was an investor at BoxGroup Ventures and the co-founder and President of Nucleate Bio, a national life sciences entrepreneurship program helping PhDs, Post-docs, and students commercialize scientific projects. Sofia earned her MBA from Harvard Business School and her BA with high honors in Chemistry from Harvard University. While in school, she conducted research alongside Bob Langer, a serial entrepreneur and one of 12 Institute professors at MIT widely recognized for his contributions to drug delivery and tissue engineering fields.

• Bio-IT World: Venture, Innovation & Partnering

My name is Pedro Ivo Guimarães (he/him) and I am a senior scientist and product manager at Roche's Data & Analytics Data Products & Platforms team. My goal is to transform how science is done at Roche's pharmaceutical research and early development (pRED) laboratories across the world. Since I joined Roche's Data & Analytics team a few years ago, I have worked on and led several digital lab automation projects and initiatives that are accelerating pRED's journey towards data-driven drug discovery. I am currently the product manager of a global digital lab automation platform that allows pRED scientists worldwide to build and share digital twins of lab workflows and automate several data processing and system integration steps. I believe that the boundaries between the physical and digital realms of science are almost non-existent in a modern laboratory environment so a human-centered digitalization process is essential to achieve the Lab of the Future dream. I am passionate about product work, so I am an advocate for good product management practices, continuous product discovery, and leading by outcomes and not outputs. I have a Bachelor's degree in Biotechnology from Universidade Federal do Pará (Belém, PA, Brazil) and a PhD degree in Biological Systems Engineering from Virginia Tech (USA). I am also an improv theater performer and director, a plant parent, a musician, and a dog person.

• W5: Digitalization of Pharma R&D-Master the Marathon
• Automation, Digital Lab, and Robotics

Rishi has over 15yrs of experience in Pharma in various capacities. He is currently an Associate Director within the GDC/CADD group at Novartis Institutes for Biomedical Research, at Cambridge, MA. He is leading several efforts in developing and applying cheminformatics, data science, AI/ML and molecular modeling methods for advancing drug discovery and development. Prior to Novartis, Rishi was at AbbVie where he led the Data Science and Informatics group. At AbbVie, he conceptualized and developed a web-based infrastructure to expose suite of Cheminformatics tools called AIDEAS. He developed and deployed machine-learning models for a variety of bioassay data including ADMET endpoints. In his extended role within Competitive Intelligence (CI), Rishi developed web based visual-analytics for several organizations.

• Generative AI
• W4: Large Language Models and Their Practical Applications within Novartis: Best Practices and Use Cases

Karl is the Director of Software Engineering at BioTeam and has been contributing to life sciences technology solutions for fifteen years. Karl's focus is on building custom software, cloud, and high-performance computing systems for scientific data and applications.

• Data Management

Ralph graduated with a Master's in Medical Informatics from the University of Heidelberg and started his professional career as a software engineer and consultant for Healthcare Information Systems. In the meantime, he has a 20+ year professional record of successfully delivering products, services, and projects to Pharma Research at both Roche and more recently Novartis. He is passionate about creating and nurturing engaging working environments based on modern agile principles and empowering leadership where talents can thrive and grow. Over the last decade he led multiple interdisciplinary teams of life science, computer and data scientists in Pharma Research Informatics. He is driven by the desire to accelerate data driven drug discovery by digitalizing and automating science and establishing data and analytics as a key research platform in pharma R&D.

• Pharmaceutical R&D Informatics

Ahmad Haider is a people-first leader and a technology strategist with deep expertise in the fields of data, machine learning, and artificial intelligence. He believes in the power of data and storytelling to change the world and has used them to build strong teams and innovative solutions to solve the most pressing problems in the life sciences, healthcare, and software industries. Coming from a diverse background himself, he believes in expanding the footprint of diversity, equity, and inclusion at home and in the workplace. His goal is to influence meaningful changes in society through better use of data and analytics.

• AI for Drug Discovery and Development
• Cloud Computing

Talia Grace Haller is a Future of Health Thought Leader and Strategy Consultant, who specializes in AI Strategy for Life Sciences and Health Care clients. Her expertise lies in understanding the art of what's possible for AI and digital transformation, then building out the business case and roadmap for integrating AI and Machine Learning into the nation’s top healthcare institutions. Talia has worked with clients all across the health ecosystem, from top-tier hospitals and provider organizations to pharmaceutical companies and laboratories, to health payers and non-traditional players entering the health space.

• Automation, Digital Lab, and Robotics

Cheng Han is TetraScience's VP of customer success. He is a subject matter expert on explainable AI, data science, digital transformation and enterprise SaaS. Cheng's expertise as a global leader at TetraScience spans customer success and product management. As a graduate of the MIT Sloan School of Management, Cheng is a member of the MIT Alumni Angels of Boston.

• AI for Drug Discovery and Development

Yvonne Hao is the Secretary of the Executive Office of Economic Development. She has had more than 25 years of executive business experience as a senior executive, including as Co-Founder, Advisor, and Managing Director at investment firm Cove Hill Partners and as an Operating Partner at Pillar Ventures. Previously, she was the Chief Operating Officer and Chief Financial Officer of PillPack, an online pharmacy that was acquired by Amazon in 2018. She is also a former Operating Partner at Bain Capital. In addition, Hao has been a Board Director of companies such as CarGurus, Flywire, Gentherm, ZipRecruiter, and Bose. She also has been involved in the community, is the Vice Chair of the Board of Trustees of Beth Israel Lahey Health, and a Trustee Emeriti of her alma mater, Williams College. She lives in Williamstown and Cambridge and is a graduate of Williams College and the University of Cambridge.

• Bio-IT World: Venture, Innovation & Partnering

Juergen Harter is CEO of The Cambridge Crystallographic Data Centre (CCDC), a U.K. charity and world-leading organization in structural chemistry data, software and knowledge for materials and life sciences R&D. He cares passionately about digital transformation, big data, knowledge management, automation, scientific and business intelligence and advancing the vision of AI for chemistry.

• FAIR Data

Peter Henstock is working to transform Pfizer using AI and Machine Learning. He is the Machine Learning and Technical Lead in Pfizer’s Digital group based in Massachusetts. He holds a PhD in Artificial Intelligence from Purdue University and Master’s degrees in Biology, Software Engineering, Statistics, Applied Linguistics, and Image Processing. Before joining Pfizer, Peter worked at MIT Lincoln Laboratory in image processing and computational linguistics. He also teaches graduate level Machine Learning & Data Mining, Image Processing & Computer Vision, and Software Engineering at Harvard University.

• Knowledge Graphs

Johannes Hermann is an early pioneer in machine learning/AI approaches to accelerate drug discovery, with over a decade of leadership experience driving healthcare innovation and hunting drugs using AI. As the global head for Data Science at Johnson & Johnson Medical Devices Technology, Johannes integrated AI into digital & robotic surgery, sensor-based patient rehab assistance, and personalized patient treatment and risk assessments. As Janssen Pharmaceuticals’ global head of machine learning and advanced analytics, Johannes drove AI initiatives across the pharmaceutical value chain, from R&D to production and commercialization. Johannes started his career at Roche as a data scientist and drug designer. Johannes holds a PhD in quantum & molecular mechanics from the University of Düsseldorf, with postgraduate work at University of Bristol and UC San Francisco. As the CTO of Frontier Medicines, Johannes is deploying AI/ML to discover and develop breakthrough drugs against ‘undruggable’ targets.

• AI for Drug Discovery and Development

As a four-year-old huddling behind the sofa, terrified and enthralled by Doctor Who battling the Daleks, David wanted to be a genius Time Lord. He now makes do by pretending to be brilliant in films and on TV. Hewlett had the pleasure of playing fan-favorite, Dr. Rodney Mckay in the People’s Choice Award-winning, Stargate Atlantis. He has appeared in numerous projects, including Guillermo Del Toro’s Oscar-winning film, The Shape Of Water, Nightmare Alley and Cabinet of Curiosities (Graveyard Rats). Other roles include CUBE, Splice & Nothing, Roland Emmerich's, Midway, Rupert Wyatt’s, Rise of the Planet of the Apes, and recurring TV roles on Clarice, Departure and opposite Jason Momoa on SEE for AppleTV. Hewlett’s passion for lifelong learning led him to create TechBandits.org, a curiosity-driven STEAM club for kids of all ages. He hosts Techbanditry sessions live on YouTube, Twitch, and in-person at local schools and community centres. David writes the popular "Email of Awesome Awesomeness", a joyful, curious, mix of inspiring technology and science stories for life-long learners of all ages. His excitement about assistive tech led him to partner with Google on GameFace, an AI-powered head-tracking mouse, released at GoogleIO 2023. And while he can get lost in a box, David has created "Know Way Out", an educational escape room design initiative that he’s developing with the University of Toronto. David is a speaker at conferences and on podcasts the world over. His goal is to inspire the next-generation of brilliant minds to “be brave, be kind, be curious”.

• AI for Drug Discovery and Development
• Generative AI
• AI for Oncology, Precision Medicine, and Health
• Bioinformatics
• Cloud Computing
• Data Science and Analytics Technologies
• Pharmaceutical R&D Informatics
• Software Applications and Services
• Modern Data Platforms and Storage Infrastructure
• Data Management

Rachael Holmes is a chemist by training with an intrinsic interest in systems, particularly with removing extraneous work from systems and processes without compromising on quality. This interest has lead her to move from bench chemistry to exploring how research informatics teams can accelerate science at scale by providing fit-for-purpose portfolios of effective, cost-conscious, secure software products that evolve continuously to meet business needs.

• Software Applications and Services

Michael is a software engineer and Product Manager for Integrations. He is currently responsible for continuous improvement to Cellario™ and Cellario™ Cloud. Before becoming Product Manager, Michael led the software team that developed Cellario™ Order Broker and integrated many software applications with Cellario, such as LabDroid and various Laboratory Information Management Systems (LIMS) and Electronic Laboratory Notebooks (ELN). Michael earned a B.S. in Robotics Engineering from W.P.I. in 2018.

• Modern Data Platforms and Storage Infrastructure

Dan is a thought leader and industry veteran in the areas of real-world data, interoperability, and clinical analytics. Dan is a co-founder and CTO of Graticule, an on-demand, advanced real-world data and advisory provider serving life science companies and health systems. Throughout his career in clinical informatics Dan has championed scalable open systems including the distribution of the i2b2 cohort selection system, creation of the tranSMART bioinformatics framework, and adoption of OMOP and FHIR. Previously, Dan founded Recombinant Data, a clinical data warehousing company serving health systems and pharmaceutical companies, which was acquired by Deloitte in 2012. While at Deloitte, Dan served as CTO of their healthcare analytics business, leading strategy for the ConvergeHEALTH portfolio of products. He also consulted with senior leaders at life sciences companies on innovation regarding AI in R&D and migration of patient data systems to cloud infrastructure such as Amazon Web Services.

• Digitization of Clinical Development and Clinical Trials

No bio available.

• Modern Data Platforms and Storage Infrastructure

Award-winning journalist Lisa Hughes is a news anchor for WBZ-TV News weekdays at 5, 6, and 11 pm. She joined the station in June 2000 after working as a correspondent for CBS Newspath, the CBS-TV Station Group's satellite news service. She was based in Washington, D.C. Lisa has covered just about every major news event in New England, and she has had the pleasure of interviewing many of the area's newsmakers. Among her many honors, Lisa received both a 2014 Columbia DuPont Award and a 2013 George Foster Peabody Award as part of WBZ-TV's team coverage of the Boston Marathon Bombings. She received an Emmy Award for Best News Anchor in 2014 and 2016 and has received both Emmy Awards and an Edward R. Murrow Award for reporting. In 2020, Lisa was named one of Boston's "100 Most Influential People" and "Best TV Personality" by Boston Magazine. Lisa is also involved in a number of community organizations and charities. She is on the board of directors of Big Sister Boston, serves on the development board at Spaulding Rehabilitation Hospital, and volunteers her time with Project 351, Children's Hospital Boston, and the Boys and Girls Clubs of Dorchester. Starting in 2011, Lisa began riding the annual Pan Mass Challenge to raise money for Dana Farber Cancer Institute. In 2002, she ran the Boston Marathon for the American Liver Foundation. Before joining CBS, she worked as a reporter and weekend anchor at KIRO-TV in Seattle, a main anchor and reporter for KBCI-TV in Boise, Idaho, and an anchor and reporter for KCBY-TV in Coos Bay, Oregon. Born in Moscow, Idaho, Lisa earned a degree in Broadcast Journalism from the University of Washington. She currently resides in Greater Boston with her husband, Mike, their daughter Riley and son Dylan.

• Bio-IT World: Venture, Innovation & Partnering

Dan Isaacs is Chief Technology Officer of Digital Twin Consortium, where he is responsible for setting the technical direction for the Member Consortium, liaison partnerships and business development support for new memberships. Previously, Dan was Director of Strategic Marketing and Business Development at Xilinx where he was responsible for emerging technologies including AI/Machine Learning, including defining and executing the ecosystem strategy for the Industrial IoT. Prior to joining the Digital Twin Consortium, Dan was responsible for Automotive Business Development focused on Automated Driving and ADAS systems. Dan represented Xilinx to the Industrial Internet Consortium (IIC). He has more than 25 years of experience working in automotive, Mil/Aerospace and consumer-based companies including Ford, NEC, LSI Logic and Hughes Aircraft. An accomplished speaker, Dan has delivered keynotes, presentations and served as panelist and moderator for IIC World Forums, Industrial IOT Global conferences, Embedded World, Embedded Systems, and FPGA Conferences. He is a member of international advisory boards and holds degrees in Computer Engineering: EE from Cal State University, B.S. Geophysics from ASU.

• W6: Biomedical Digital Twins

Mark Jackson, Data Engineer, Data Science Mark is a member of the Translational Data Engineering and Solutions team within Johnson & Johnson Innovative Medicine R&D Data Science Solutions, Privacy & Ethics. The mission of the team is to manage and organize JNJ translational research data and to deliver innovative platforms and tools that utilize this data to contribute towards effective and timely portfolio decisions. Prior to joining JNJ, he earned his M.S. in Computational Science and Engineering from the Georgia Institute of Technology.

• Data Management

I have been a data scientists throughout my career. I have lived the pain of data scientists everyday and hence I switched the gears from being a consumer of the data and platforms to become enabler made me working towards the subject of improvising data and platforms with the technology advancements and ML techniques

• Generative AI

Senior Digital Transformation leader-specializes in leading large-scale data platforms with deep expertise in Data Mesh, Lakehouse, Enterprise Data Lake, AI/ML, and Advanced Analytics, with managing the collection of systems, business applications, and SaaS, PaaS, IaaS products.

• Quantum Computing
• Automation, Digital Lab, and Robotics

Brian Jamieson is focused on seeing the company’s core technology, which is based on his doctoral thesis at the University of Michigan, deepen our understanding of the human brain and help develop treatments and cures for the crushing burden of neurological disease. Prior to founding DBC, Brian worked for NASA, developing analytical instrumentation for unmanned space missions, and later founded and sold an engineering services company.

• Automation, Digital Lab, and Robotics

Dr Daniel Jamieson founded Biorelate after supporting the successful identification of drug repurposing opportunities with Pfizer in a groundbreaking project to curate the first-ever knowledge graph to represent the pain interactome. Biorelate is now the leading provider of contextualised data and cause-and-effect data insights, curated via best-in-class large language models, AI and NLP; Daniel’s focus remains on helping pioneering biopharma companies in their mission to develop life-saving innovations.

• Bioinformatics

No bio available.

• Digitization of Clinical Development and Clinical Trials

Domen is a senior product manager for AWS HealthOmics. He is responsible for listening to customers, defining requirements, and ensuring that Amazon Web Services (AWS) helps customers advance scientific discovery and precision medicine. Domen has over 10 years of experience delivering technical and machine learning solutions across many industries including Biotech, Life Science, Healthcare, Pharmaceutical and Medical Device. He also continues to pursue research at the junction of bioinformatics and ML.

• Cloud Computing

Aaron has been building and running workloads in AWS since the initial days of S3.  With leadership roles at Hasbro and Brightcove, Aaron leads PTP's cloud consulting practice addressing challenges with data management in Life Sciences and offering insight into architectural designs and engineering to achieve the results PTP's clients expect.  Aaron is an AWS Solutions Architect Professional, but that is just part of the story with his vast experience.

• Software Applications and Services

Dave has spent the majority of his 20+ year career building data integration and analytics solutions for the life sciences and healthcare industries.  His experience includes building custom solutions (Deloitte, DRG) and products (PerkinElmer, DRG, iSpecimen) that leveraged open source (i2b2, tranSMART) and commercial solutions (AWS, Snowflake, Spotfire, Qlik, …) to enable organizations to develop insights and unlock the value of their data.

• Digitization of Clinical Development and Clinical Trials

Johannes Hermann is an early pioneer in machine learning/AI approaches to accelerate drug discovery, with over a decade of leadership experience driving healthcare innovation and hunting drugs using AI. As the global head for Data Science at Johnson & Johnson Medical Devices Technology, Johannes integrated AI into digital & robotic surgery, sensor-based patient rehab assistance, and personalized patient treatment and risk assessments. As Janssen Pharmaceuticals’ global head of machine learning and advanced analytics, Johannes drove AI initiatives across the pharmaceutical value chain, from R&D to production and commercialization. Johannes started his career at Roche as a data scientist and drug designer. Johannes holds a PhD in quantum & molecular mechanics from the University of Düsseldorf, with postgraduate work at University of Bristol and UC San Francisco. As the CTO of Frontier Medicines, Johannes is deploying AI/ML to discover and develop breakthrough drugs against ‘undruggable’ targets.

• AI for Drug Discovery and Development

No bio available.

• AI for Oncology, Precision Medicine, and Health
• Bioinformatics

Atul is data science manager at ZS who leads AI product and services for Pharma R&D. He has been bringing innovative ZS AI/ML solutions to the market for last 10 years. He is working on multiple ZS flagship offerings such as discovery knowledge graphs, GenAI based solutions in trial design, feasibility planning and execution.

• Generative AI

Kyle Kai-How Farh, MD, PhD has been leading the Illumina Artificial Intelligence Lab for 9 years. Prior to joining Illumina, Dr. Kai-How Farh spent time as an attending physician at Boston Children’s Hospital and as a Fellow at The Broad Institute. He holds an MD from Harvard Medical School, a PhD in molecular biology from Massachusetts Institute of Technology, and a BS in computer science from Rice University.  

• Data Science and Analytics Technologies

No bio available.

• Digital Biopharma

Mirella has a background in computer science and bioinformatics and did her PhD at Maastricht University investigating obesity associated health complications. She wholeheartedly supports open science towards better health care. That’s why Mirella joined Hyve in March 2021 in the role of Project Manager/Business Analyst. She hopes that her expertise can be of great help in the Hyve’s vision “Everyone in life sciences works together towards better health”.

• Bioinformatics

Petrina Kamya, Ph.D., is the VP, and Global Head of AI Platforms and President of Insilico Medicine Canada, overseeing Insilico’s end-to-end generative AI-driven drug discovery platform, Pharma.AI. Before joining Insilico, Dr. Kamya's career spanned many key stages of the drug discovery value chain from the early stages to commercialization. She holds a Ph.D. in chemistry and a BS in biochemistry from Concordia University.

• Cloud Computing

No bio available.

• Cloud Computing

Gurpreet has been working as a Program manager for more than 14 years with experience of 28 years in IT technical project planning and implementation industry. He helped establishing the PMO at his company and has managed many complex projects globally. Gurpreet works closely with customers and portfolio managers to help them resolve specific issues and problems regarding the programs & projects. Gurpreet has MBA Degree from Edinburgh Business School and Bachelor of Engineering in Computer Science.

• Software Applications and Services

Dr Misha Kapushesky, previously the Functional Genomics group leader at the EBI in Cambridge, founded Genestack in 2021. Misha has used the past 10 years to establish a tightly knit group of experts that enable their mission - to make the best use of data to improve lives. 

• Data Management

Fredrik Kartberg is a Technical Associate Director at Novartis Biomedical Research. His journey started with an M.Sc in pharmacy, continued into the laboratory to fulfill a PhD in Cell Biology, and thereafter he was catapulted into the pharmaceutical industry as a research scientist focusing on biologics. Since 2021, Fredrik has worked as a scientific product manager in Biomedical Research with a focus on entity registration and sample management tools. He has been passionate about improving the efficiency of end-to-end processes and informatics support for emerging therapeutic modalities.

• Digital Biopharma

Experienced Co-Founder with a demonstrated history of working in the biotechnology industry. Skilled in Biophysics, Computer Science, Amazon Web Services (AWS), Algorithms, Programming, and Python. Strong information technology professional with a Master of Science (MSc) focused on Biomathematics, Bioinformatics, and Computational Biology from the Massachusetts Institute of Technology.

• Automation, Digital Lab, and Robotics

As a venture partner at Third Rock, John works with the platform team to develop, implement and refine technology roadmaps for companies across our portfolio with a focus on the identification and integration of drug discovery and development technology platforms. Prior to joining Third Rock, John was the vice president of information technology and informatics at Infinity Pharmaceuticals where he was responsible for information systems, software development, computational science, biostatistics, clinical data management and clinical informatics. Over the course of almost 13 years at Infinity, John had the unique opportunity to play a critical role in the genesis and evolution of the company's science, technology and business. John, who has proven to be a sucker for worthy charities, once allowed his coworker to shave his head with a Flowbee to raise money for a local nonprofit organization focused on cancer patient support.

• Bio-IT World: Venture, Innovation & Partnering

An accomplished leader with a keen understanding of the dynamics that impact developing and bringing products to market. 15+ years of computational chemistry experience, including the previous 10 years in senior scientific and operational leadership positions. Experienced at working at multiple stages of R&D process with experience leading multiple, concurrent projects at varying stages of development. Excels at integrating scientific goals and capabilities with business objectives to craft a cohesive go-to-market strategy. Outstanding communication skills, leadership ability, and business acumen

• Quantum Computing

William Kerilla is a Sr. Manager, Regeneron IT leading the Regeneron laboratory technology support team at the Tarrytown Research site. The team supports scientific instrument and research technology both in the laboratories and as part of the larger technology landscape. Prior to working at Regeneron, he worked over a decade at Sanofi Pharmaceuticals in various global and regional IT roles supporting the organization’s research strategies.

• Automation, Digital Lab, and Robotics

Dr. Shameer Khader is a senior director of advanced analytics, data science, and bioinformatics at AstraZeneca, a global, science-led biopharmaceuticals company. At AstraZeneca, he leads a global team of data scientists, biomedical scientists, statisticians, and software engineers. He oversees a portfolio of projects in oncology and biopharma to accelerate drug discovery and development using biomedical and clinical big data using machine intelligence approaches. He has published more than 120+ peer-reviewed research papers, patents and conference publications in pharma informatics, healthcare data science, bioinformatics, drug discovery, and precision medicine. Various national and international media, business, biotechnology, and scientific publishers have featured his work. His work was featured in media outlets including Forbes, FastCompany, Bloomberg News, Times of India, The Indian Express, HealthITAnalytics, ScienceDaily, The Sun, MedScape, Medical Express, MedPage Today, The Economic Times, Cardiology Today, NewsWise, BioPortfolio, Science Xpress, Business Standard, eCancer News, PhysOrg, UroToday, etc. His work was also featured worldwide publications and includes blogs by MedGadget, UNESCO, International Society for Computational Biology, American Chemical Society, American Heart Association, and the NEJM-Journal Watch.

• Data Management

Rania is responsible for the engineering, data, AI, and IT capabilities at the foundation of Inari’s cutting-edge SEEDesign technology platform. She has an extensive track record of leading and delivering award-winning innovation in cloud-native AI platforms, human-centered AI, serverless computing, and web services. Rania joined Inari from IBM Research, most recently as Director of AI Platforms, where she led the global AI-infused automation research strategy and oversaw the creation and launch of innovation in multiple new and existing AI-driven products. A board member of the Hariri Institute for Computing at Boston University, she received her doctorate from the University of Stuttgart and her master's and bachelor's degrees from the Massachusetts Institute of Technology.

• Modern Data Platforms and Storage Infrastructure

Yiannis is the CEO and Co-Founder of Causaly, a leader in R&D Analytics that allows researchers to navigate the intricate landscape of biomedical research. He is a computer scientist and passionate about knowledge engineering and has previously consulted with the world's largest companies for more than 10 years. Yiannis holds a Bachelor and Master’s in Computer Science and an MBA from Hong Kong University of Science and Technology.

• AI for Drug Discovery and Development

Kerstin Kleese van Dam (2018 Woman of the Year Award in Science winner Brookhaven Town, 2006 British Female Innovators and Inventors Silver Award) is the Director of the Computational Science Initiative at Brookhaven National Laboratory in the USA, leading BNL's computer science and mathematics R&D portfolio reaching from leading edge research to operational infrastructure provision. CSI research focuses on data analytics @ scale - novel hardware to new AI methods for science, exascale computational modeling and quantum information science - quantum networking to optimized quantum algorithms for high energy, nuclear and condensed matter physics. We have a new, state of the art data center opened in 2021, that provides leading edge data storage and analysis capabilities.

• W6: Biomedical Digital Twins

Kristian obtained his BSc in Natural Sciences from the University of Pittsburgh and began his career at Pfizer Vaccines R&D. During his 4 years at Pfizer, Kristian transitioned from bench science to a business analytics capacity leading several digital transformation projects supporting Pfizer’s clinical VR&D portfolio with a focus on assay data management, harmonization of data standards, and clinical study resourcing systems with a goal of clarifying constraints, efficiencies, and gray areas for leadership. In his current role at Regeneron as a Principal Business Analyst in Research, Kristian employs an entrepreneurial mindset and team-centric approach to discover emerging technology, showcase product capabilities define proof-of-concept plans, validate prototypes, communicate value-add to leadership teams, and strategize implementation at scale. He is responsible for driving the Streamlining Experimental Data Capture product suite, consisting of several technologies spanning extended reality, voice assistance, thermal imaging, and automated animal identification to facilitate scientific discovery.

• Modern Data Platforms and Storage Infrastructure
• Automation, Digital Lab, and Robotics

Robert Krueger is an assistant professor at New York University (NYU). Previously, he was a postdoctoral research fellow and subgroup leader at VCG Harvard, School of Engineering and Applied Sciences at Harvard University, and a senior research scientist at the Laboratory of Systems Pharmacology, Harvard Medical School. Dr. Krueger received his MS in Computer Science and Media at the Stuttgart Media University in 2012 and his Ph. degree (Dr. rer. nat.) in Computer Science at the Institute for Visualization and Interactive Systems, University of Stuttgart in 2017. Krueger's research interests lie in the field of data visualization and visual analytics for on spatial and spatially-referenced multivariate data with a focus on biomedical visualization.

• Bioinformatics

Emilia Kruzel PhD leads Business Development at Syntekabio USA. Previously, she developed digital therapeutics and precision digital health tools at Propeller Health, and e-clinical solutions for clinical trials at ERT. Her PhD is in Biomolecular Chemistry from the University of Wisconsin-Madison, and her Postdoctoral work on tropical diseases was awarded a Ruth Kirschstein National Research Fellowship from the US National Institutes of Health.

• Bioinformatics

Carl Kuesters is Principal Software Engineer at Novartis Biomedical Research in Basel. Growing up in Germany, Carl holds a BSc in Computer Science from the University of Freiburg. Since then, he has led multiple engineering teams in developing innovative solutions, ranging across different business domains during a 5-year period as external contractor, before finally joining Novartis in March, 2022. Most recently, he is working as a tech lead and engineer on an in-house application to capture and provide FAIR in vivo data, with the goal to accelerate drug discovery.

• AI for Drug Discovery and Development

My goal is to apply my expertise in automation, assay development, and high-throughput screening as well as biochemical and biophysical characterization of proteins to discover and develop novel biologics.

• Automation, Digital Lab, and Robotics

Lakshmi Kuttippurathu is an accomplished interdisciplinary scientist with 15+ years of experience in computational biology. During her research career at Harvard MIT Health Science and Technology, Lakshmi developed a computational tool, to study regulatory dynamics of transcription factors. As a postdoctoral fellow and later as a faculty member at Thomas Jefferson University, she contributed to the field of liver regeneration and Neuroscience with a focus on understanding regulatory network dynamics driven by perturbations, using Systems Biology approach. Currently, she is the Associate Director, Computational Biology and Data Sciences at Lexicon Pharmaceuticals, where she is spearheading the computational efforts on developing and implementing a strategy for preclinical target discovery.

• Bioinformatics

Steven Labkoff is one of the leading clinician-informaticians in the US today with nearly 30 years of experience in the life sciences and healthcare sector. Trained in medical informatics, cardiology, and internal medicine (Harvard, MIT, University of New Jersey, and University of Pittsburgh), Steve has deep expertise in generating, managing, and analyzing data to accelerate drug development, personalize patient care, and improve medical outcomes.

• AI for Drug Discovery and Development

Abi Lakshmanan is an Associate Director at Novartis Biomedical Research, leading the standardization of omics workflows. She has over 15 years of experience in the bioinformatics data industry for pharmaceutical applications. Abi is passionate about making omics data FAIR, to unlock its value and synergies across research, beyond the original scope of individual studies.

• Automation, Digital Lab, and Robotics

Dan Larsen: Started career as a research coordinator/research project manager where I was responsible for building out research infrastructure mechanisms in standard-of-care treatment settings at two different comprehensive cancer centers. I was in clinic working closely with clinical teams 60-70% of the time and the other 30-40% of the time was spent chart auditing/clinical data abstraction activities. I have extensive experience working with EMR systems including Epic, Cerner, and IKnowMed. I have been with abbvie for 6 years working in a data analytics/data science role developing the use of RWD for Clinical Trial Enablement activities. I carry a passion for finding ways to empower sites and reduce trial burden.

• Digitization of Clinical Development and Clinical Trials

Dave received his Ph.D. in chemical and biomolecular engineering from North Carolina State University and went on to get his MBA at Wharton. He began his career at The Janssen Pharmaceutical Companies of Johnson and Johnson, working in a group that was responsible for overseeing the manufacturing of large molecule antibodies, and was the youngest person ever to lead an AI research group at J&J. Dave also led flagship programs for the company’s AI Advanced Center of Excellence, and enabled J&J’s billion dose commitment during the COVID pandemic. Before leaving J&J and pursuing his MBA, Dave was inducted into Frontiers of Engineering, an organization created by the National Academy of Engineering to recognize top early-career engineers. While studying at Wharton, the idea of BioPhy originated and later evolved into a life sciences health tech company in 2020. Dave examines opportunities down to first principles using a blend of business acumen, analytics, and the scientific process to use artificial intelligence and biophysics concepts to bring value to the healthcare value chain. In his personal life, Dr. Latshaw is a proud husband, father of two beautiful daughters, and an avid endurance athlete.

• Bio-IT World: Venture, Innovation & Partnering

After a Bachelor’s degree in computer science and statistics I joined a CRO company as Statistical Program Leader working for various pharmaceutical companies then I joined Sanofi in 2006 as Statistical Programming Lead. I worked for 7 years as Statistical Project Leader and managed statistical programmers’ teams on building statistical clinical analysis in preparation of the dossier for submission to the health authorities. Then in 2013, I joined the Sanofi Digital R&D team as Product Owner of the Statistical and Analytical platform for clinical and took over the position of manager of the Statistical & Analytical Digital team for clinical. I oversaw the development of new digital solutions for clinical activities. In 2021, I moved into my current position of iCMC Digital Program Leader starting with the deployment of the Biovia Science Cloud platform across all CMC Sanofi labs and continuing now with the CMC Full Transformation activities.

• Automation, Digital Lab, and Robotics

No bio available.

• Modern Data Platforms and Storage Infrastructure

Pat obtained his BSc in psychology and a Master's in Research in Psychiatry from McGill University. He started his pharmaceutical career at AstraZeneca as an in vivo scientist. He subsequently transitioned into the world of IT, holding multiple positions from business analyst, project manager, program manager, capability leader to name a few. He has spent 28 years in the Pharma and BioTech industries, including AstraZeneca, Novartis, and for the past 6 years at Regeneron. As Director Business Relationship Management at Regeneron, Pat supports multiple Therapeutic Focused Areas focusing with his team on the implementation of any and all XR technologies as well as digital technologies such as thermal scanners, RapID tags, RFID and virtual lab assistant technologies that can help our scientist be more efficient, productive and overall happier while increasing data quality, compliance and ensuring work life balance for all his stakeholders.

• Modern Data Platforms and Storage Infrastructure
• Automation, Digital Lab, and Robotics

Andreas Lehmann is currently leading the Digital Science group at EMD Serono in Darmstadt, Germany. In this role, he is responsible for spearheading digital innovation initiatives, driving data-driven strategies, and overseeing the integration of digital technologies in the field of drug product development. Prior to his current role, Andreas conducted extensive research on the risks and countermeasures of poor-quality drugs in an international context during his PhD studies. He also gained valuable experience as a Scientific Expert at Merz Consumer Care GmbH, where he worked in both scientific and regulatory affairs. As a Post-Doc at GaleniCon and a Biopharmaceutical Scientist at EMD Serono, he contributed to the development of new in vitro/in silico prediction techniques.

• Pharmaceutical R&D Informatics

Jeff Lengyel is a Research and Applications Scientist at the Cambridge Crystallographic Data Centre (CCDC). He holds a PhD in Materials Chemistry from Florida State University where he studied functional phase transitions in hydrogen-bonded molecular materials. He is also interested in applying data science and machine learning to problems in chemistry and materials. He currently lives in Pittsburgh, PA with his two cats - Biscuit and Gravy.

• AI for Drug Discovery and Development

Explore how two leading biotech companies and a top cloud company are fast tracking pharmaceutical R&D. Insilico Medicine will discuss the use of generative AI to cut costs/time in producing life-saving medications. Meliora Therapeutics will detail scaling a multi-modal AI-powered mechanism deconvolution platform to change the oncology drug development lifecycle. Oracle ties it all together to share how their partnership with NVIDIA is helping fuel the drug discovery ecosystem.

• Cloud Computing

Michael N. Liebman, PhD (theoretical chemistry and protein crystallography) is Managing Director of IPQ Analytics, LLC and CSO of United Cancer Centers after serving as Executive Director of the Chan Soon-Shiong Institute for Molecular Medicine. He is Adjunct Professor of Pharmacology and Physiology, Drexel College of Medicine and Adjunct Professor of Drug Discovery, Wenzhou Medical University and Fudan University. He serves on the Advisory Board for the Center of Biomedical and Health Research, University of Massachusetts (Lowell). Previously, he was Director, Computational Biology and Biomedical Informatics, University of Pennsylvania Cancer Center. He served as Global Head of Computational Genomics, Roche. He serves on the Board of the Nathaniel Adamczyk Foundation in Pediatric ARDS. Michael chairs Translational Medicine for the PhRMA Foundation and serves on the IUPAC Division on Human Health. His research focuses on computational models of disease that stress complexities of real-world patients and real-world clinical practice utilizing systems-based approaches for representation and analysis for pharma and healthcare.

• Knowledge Graphs

Yuan Lin is the Biologics Business Partner and Solution Lead in Pfizer Digital. He manages, develops, and supports Pfizer Biologics R&D informatics platforms. He has 20+ years of experience in bioinformatics, business system analysis, and software development. Before joining Pfizer in 2017, Yuan was a Senior Principle Business Analyst and Lead Software Engineer at Novartis, focusing on the in-house E2E biologics screening platform and leading the support of a global biologics registration platform. He led the implementation of an industry-first clinical NGS genetic testing data workflow system at GeneDX and built a comparative Genome Browser and Sequence Analysis platform that enabled the sequencing and analyzing of the first individual human genome at J Craig Venter Institute.

• Digital Biopharma

Dr. Yi Lin has 16+ years of experience in the life science and pharmaceutical industry. After joining Roche R&D Center (China) Ltd. In 2012, he gained experience in many different areas: informatics landscape build-up, discovery workflow optimization, advanced data analytics with machine learning and deep learning, digital automation, and cloud computing. He is innovative in developing AI solutions to address drug project needs with more than 10 scientific impacts. He also has extensive experience in informatics and digital project management including leading a Roche global digital project which brings an AI chemistry cloud-based platform across three Roche research sites (pRED, gRED, and CICoR). He is now leading the AI, Data, and Digital (AIDD) department in China Innovation Center of Roche (CICoR) to enable the transformation of drug discovery and early development through AI and digitalization.

• Pharmaceutical R&D Informatics

Samantha Lipsky (she|her) is an Associate Director in the Data Science Institute at Takeda, currently specializing in technical solutions for metadata-driven data harmonization in Clinical Data Sciences. Sam started her career as a Bioengineering postdoc focusing on biomedical microscopy and tissue engineering applications, and later transitioned to the pharma industry as a technical professional with bench expertise. She spent 8 years at AbbVie in Data Solutions and Information Research. Later as a Data Scientist in late-stage development at Biogen, she worked to devise methods to standardize and structure SOP metadata using text mining, an application ontology, and creating a full-stack app. Presently, she provides tools to reinforce data harmonization to scientists to aid in their use of semantics and contextual data management.

• W3: Semantic Management Technologies and Processes: An Agile Framework to Enable Innovation

Sean Liu is head of Scientific Assets & Decision Support in Scientific Informatics of Data Science Institute at Takeda. Sean is a biologist by training and has worked in the bio/pharmaceutical industry for the past 20 years in the area of scientific informatics and data science. His team in Takeda is involved in unleashing the power of data by data integration, contextualization, visualization, exploratory analysis, and predictive modeling to support data driven decision making.

• Pharmaceutical R&D Informatics

No bio available.

• Software Applications and Services

Mike Livstone is graduate of Yale University (B.S., Molecular Biophysics and Biochemistry) and Columbia University (Ph.D.; Cellular, Molecular, and Biophysical Studies). After a postdoc at Princeton, he taught biology labs at Temple University for a year, then returned to Princeton as a Scientific Database Curator and worked on a number of free, public academic databases. In 2015, he joined Celgene (later BMS). Mike has been at Regeneron, where he is the Scientific Data Curation Lead, since 2020.

• FAIR Data

Rana Lonnen is a healthcare technology investor, entrepreneur, and molecular biologist. At Novartis, she leads strategic investments in technology companies, on a mission to transform the healthcare ecosystem and make positive impact on people’s lives. Previously, Rana was Head of Preclinical Development at a UK biotech, Auspherix; investment consultant to IP Group in London; Founder and CSO of a UK-based Biotech, Axendos therapeutics. Prior to this, she was a Wellcome Trust-backed principal investigator in drug discovery in the field of Infection, Immunity, and Inflammation, author and inventor on high impact peer-reviewed publications and patents; before this, Rana worked at Bristol-Myers Squibb, in sales and marketing. Rana holds a PhD in molecular biology and an MBA from Imperial College London. She personally cares about equitable healthcare, social justice, sustainability, and the future of antimicrobial resistance. In her downtime, Rana likes to make culinary experiments, be in nature, and read. Rana is a board observer at Aktana, Cota Healthcare, H1 Insights, Koneksa, Mekonos, NuvoAir, and Dopavision. She is based out of Basel, Switzerland.

• Bio-IT World: Venture, Innovation & Partnering

Enterprise and Solutions Architect at the Emerging Technologies Division at the National Labs (MITRE) with accomplished career in a variety of industries. Much of his work centers on the medical research domain. As a skilled engineer, Ray has demonstrated the ability to architect, build, and mentor others in converting complex systems into simple component-based solutions. Ray’s current interest is in high-performance, agile graph databases/analytics, machine learning, and distributed systems.

• Knowledge Graphs

Gabriel is a Research Engineer at Sanofi in their Cell Culture Development group. He holds his Bachelor's in Bioengineering from UMASS Dartmouth. His interest is in continuous processing, High-throughput development, digital transformation, automation, and data science.

• Automation, Digital Lab, and Robotics

Dr. Scott Lusher is currently Head of Technology for Discovery at Johnson & Johnson Innovative Medicine, with overall responsibility for the digital strategy supporting its modality agnostic Therapeutics Discovery and Preclinical Sciences and Translational Safety organizations. Prior to joining Johnson & Johnson, he was a founding director of the Netherlands eScience Center and contributor to the original FAIR principles workshop and article. Dr. Lusher spent more than ten years as a computational chemist, providing the molecular and structure-activity rationale for new molecular design, evaluation, and selection at Merck (Schering-Plough & Organon), and spent several years as a molecular informatics project leader at Unilever Research. He holds a PhD in Structure-Based Drug Design from the Radboud University in Nijmegen, an MSc in International Biotechnology from De Montfort University, and a BSc in Applied Molecular Biology from the University of Leeds.

• Pharmaceutical R&D Informatics

Dr. Lynch has over 25 years’ experience in Data science & Informatics in various start-ups and biopharma. He is interested in making data more accessible for better analysis, and established Curlew Research in 2014, working with pharma/biotech and life science informatics/data science companies.

• FAIR Data

No bio available.

• Data Science and Analytics Technologies

Ravi is a computer scientist at Argonne National Laboratory. He works in the intersection of high performance computing and life sciences. He leads the Globus Genomics project (www.globus.org/genomics), which is widely used for genomics, proteomics, and other biomedical computations on Amazon cloud and other platforms. See https://www.globus.org/genomics/publications for some relevant publications. He also architected the Globus Galaxies platform that underpins Globus Genomics and several other cloud-based gateways. Ravi Madduri is a key member in multiple NIH, NSF and DoE projects

• Data Science and Analytics Technologies

Asha is a director in the Data Sciences, Platforms and Privacy group. Her expertise lies in strategizing and managing data science platforms to manage high-dimensional & large-scale datasets and development and deployment of AI & digital health applications in clinical workflow. Asha has been with Johnson & Johnson for over 15 years. She successfully led major initiatives for commercial and R&D functions with strong focus on data, analytics, and customer engagement.

• Cloud Computing

Ohad is currently the Director of Computational Biology and Data Science at Century Tx, an early clinical-stage company in the Cell Therapy space. In that capacity, he gets to work with very smart people on developing computational pipelines to characterize Century's cell products, building self-service tools for Century's scientist, and support Century's first ongoing clinical trial. Ohad holds a PhD in Computer Science from the Weizmann Institute of Science, and has over nine years of experience using in-depth knowledge in computational biology, bioinformatics, and machine learning to advance research and clinical development projects.

• Digital Biopharma

No bio available.

• Modern Data Platforms and Storage Infrastructure

Brian joined AbbVie in 2018 as the head of the newly formed RAIDERS team within Research & Development’s Information Research division, focused on accelerating, scaling, and amplifying the work of AbbVie’s R&D community using Artificial Intelligence technologies like machine learning, deep learning, graph computation, and cognitive computing. Brian is a part of the leadership team building and directing the AbbVie R&D Convergence Hub (ARCH) as part of the R&D Convergence initiative and a member of the ACOS Scientific Innovation Council. Brian came to AbbVie after spending five years in technology consulting across many industries, and over a decade of additional experience before that working in trading and financial markets technology. During his consulting time, Brian was the architect of the United States’ Common Securitization Platform and the technology founder of Publicis.Sapient’s AI practice. While his primary focus is AI technologies, he was also a co-founder of the QuPharm quantum computing community and the Pistoia/QED-C Quantum Community of Interest. He is a frequent presenter at conferences on topics as diverse as optical networking, quantum computing, blockchain, cognitive architecture, and other emerging technologies that are all part of digital transformation. Brian holds a B.S. degree in Computer and Cognitive Science from Alma College and a M.S in Computer Science from the University of Chicago. He is a board member for the Chicago Innovative Executives League and for the Mundelein High School Business Incubator program. He has been involved with the Creative Destruction Lab at the University of Toronto’s Rotman School and as a panelist/reviewer for the National Science Foundation Secure and Trusted Cyberspace grant division. Brian lives in Lake Bluff, Illinois with his wife and four children.

• Generative AI
• Data Science and Analytics Technologies
• Quantum Computing
• Pharmaceutical R&D Informatics

Bret Martin is the Principal Cloud Architect at Generate:Biomedicines, where he is responsible for cloud architecture, operations, and security. Bret's previous experience includes H3 Biomedicine (research computing on AWS), HubSpot (technical operations on AWS), Harvard Medical School (high-performance computing), and VA Linux Systems (professional services).

• Cloud Computing

Bahador Marzban is a leading Senior Digital Health Data Engineer at Johnson & Johnson, specializing in data science, wearable devices, and predictive modeling with digital health data. With a background as a Data Scientist at Daxor, he developed innovative algorithms and predictive models for wearable technologies. Holding a Doctorate in Engineering, his research focused on cell motility modeling. During his postdoctoral fellowship at the University of Michigan's Medical School, he specialized in cardiovascular systems and multiscale predictive models for heart failure patients. Currently at Janssen Pharmaceuticals, Bahador spearheads digital health transformation, converting vast data into valuable insights. He excels in creating disease-specific digital health biomarkers, implementing precise data extraction algorithms, and enhancing data processing solutions in regulated environments. His multifaceted contributions drive advancements in cardiovascular health, neuroscience, immunology, and beyond, establishing him as a leader in digital health research.

• Cloud Computing

Rob Masson is an experienced international speaker and recognised data protection thought leader, actively driving innovation and transformation in privacy matters across the life sciences. He is the founder and CEO of The DPO Centre Group, one of Europe’s largest data protection service providers. The DPO Centre has assisted over 800 clients globally, including a wide range of bioscience, genomics, therapeutics, healthcare and pharma organisations. In addition to ensuring compliance with the GDPR, Rob and The DPO Centre team provide advice and support for transatlantic data sharing and other privacy regulations such as the EU Clinical Trials Regulation and France’s MR-001.

• Data Management

Ian leads the full lifecycle of application design, architecture, development, and quality assurance. Ian has over 17 Years of software development and leadership experience working for Lockheed Martin, Ernst & Young, Brulant, and Rosetta.

• AI for Oncology, Precision Medicine, and Health

A globally oriented technology executive leading research, biotech, and consumer products organizations through complex changes. I have built organizations for explosive growth, consolidated them in business downturns, and led merger/acquisition/divestiture programs. I have led teams in 20+ countries, led all aspects of IT including major business transformations and culture change across organizations. I am an adept strategic thinker with experience advising several early stage biotech firms, an advisory board member to a software startup, and board chair for large ($100M+) social services agency. I have set technology strategy, implemented global programs, fixed broken operating models, rebuilt teams, negotiated large scale partnerships, and always focused on business success.

• Bio-IT World: Venture, Innovation & Partnering

For 30 years of professional activity at PSNC, Cezary has been involved in building Polish Cyber Infrastructure for science. He has participated in many national and international research and development projects, focused on advancing technologies and services and fostering the digital transformation of science, industry and society. In his R&D activity, Cezary is mainly focused on integrating a variety of specialized software components into consistent systems for scientific experiments and end-user network services, with his scientific interests on big data analysis. PSNC is affiliated to Institute of Bioorganic Chemistry Polish Academy of Sciences and is recognizable in Europe as an institution which is focused on infrastructure-led innovations and building and operating digital platforms for data archiving, processing and delivery. Currently it employs over 500 people.

• AI for Oncology, Precision Medicine, and Health
• Bioinformatics

Janice McCallum is managing director of Health Content Advisors. She is a respected analyst in the economics of publishing and has been actively involved in creating and marketing information products for over twenty-five years. She has held senior-level product management and content development positions in pioneering information companies, including Individual, Inc. (now part of Acquire Media), Dialog Information Services (now part of ProQuest), and DeepCanyon, a Hewlett-Packard company. After receiving her MBA from the Booth School at the University of Chicago, she began her career in online publishing at Dialog where she managed several financial and business database product lines and was responsible for licensing content from dozens of publishers. Janice expanded her content development and licensing expertise into healthcare, life sciences, market research, and news information products at both Individual, Inc. and Hewlett-Packard’s DeepCanyon and has leveraged that experience in her consulting practice. Clients have ranged from major publishing firms, including Thomson Reuters, Elsevier, D&B, McGraw-Hill, Hewlett-Packard, Microsoft, to scores of many smaller publishing, technology firms, and private equity firms. Janice is a frequent speaker at industry conferences on topics from Big Data in Scholarly Publishing to business models for data content. She was on the board of trustees at the Journal of Bone & Joint Surgery from 2014 through 2022 and led the Strategy Committee for JBJS.

• Knowledge Graphs

Erin is currently an Operating Partner for Amplify and Program Director for Brigham Ignite, an early-stage innovation acceleration program focused on advancing discoveries with clinical and commercial potential by guiding researchers through the development process. Previously Erin was the Deputy Director and Senior Project Manager in the Boston Biomedical Innovation Center (B-BIC), a life science accelerator program funded by the National Institutes of Health. Projects receiving B-BIC awards have generated over 20 times their initial return on investment. Prior to that, Erin developed her expertise in medical device product development and commercialization at Boston Scientific in a variety of roles. She started her career in Research and Development at Boston Scientific and launched several vascular graft and peripheral embolization products before shifting her focus to identifying and implementing company-wide product development lifecycle process improvements. She received her MBA and MS degrees from Babson College, her BE from Stevens Institute of Technology, and holds 9 issued patents. Erin is also a board observer at Platelet Biogenesis, and Third Pole Therapeutics.

• Bio-IT World: Venture, Innovation & Partnering

John McLoughlin is a Director, Regeneron IT and supports the technology needs of Regeneron’s Research and Pre-Clinical Development laboratory systems. His team supports instrumentation and data management of Research and Pre-Clinical Development laboratory systems at Regeneron. He is an experienced professional with over 20 years in the Laboratory IT space. Prior to joining Regeneron, he was responsible for IT support of laboratory systems at Boehringer Ingelheim.

• FAIR Data
• Automation, Digital Lab, and Robotics

I'm ensuring that Quantum and Generative AI applications deliver value. I have gained vast hands-on experience in the field of Machine Learning and the intersection of Quantum Computing. As Co-Technical Lead for the Center of AI in Munich, I'm conducting state-of-the-art research in Machine Learning such as Generative AI and facilitating innovation for industrial clients from around the world.

• Quantum Computing

With over a decade of experience spanning from programming and research up to business stakeholder management, he has demonstrated proficiency in delivering complex solutions in artificial intelligence, software development, and applied mathematics. His expertise extends across a variety of sectors, including pharmaceuticals, high-tech, government, and education. During his recent five-year tenure at Novartis, he made significant strides. Initially, he focused on optimizing commercial activities through AI applications, collaborating closely with the European leadership team. In the following three years, he played a pivotal role in the development of AI solutions for small molecule design, partnering with numerous teams across the company and with Microsoft Research.

• W4: Large Language Models and Their Practical Applications within Novartis: Best Practices and Use Cases

Sumona Mitra is a Pharma Data Specialist currently leading the Customer Solutions team at Excelra. With an M.Sc. in Bioinformatics from King’s College, London, Sumona has become a key player in developing sophisticated data solutions for Pharma and Biotech in their digital transformation initiatives. Sumona's expertise extends to optimizing data workflows, enhancing accessibility, and fostering collaboration between data professionals and drug development scientists. 

• Digital Biopharma

No bio available.

• AI for Drug Discovery and Development

Ryan Mork is the Senior Director of Data Science at Evozyne, Inc., leading the design team in using deep learning to develop therapeutic products and advanced research in generative models. He received his PhD in Biophysics at the University of Chicago, and continued as a data scientist at Tempus, Inc., where he used machine learning techniques to structure multi-modal cancer datasets for personalized medicine approaches.

• Generative AI

Joe Mullen, Director of Science & Professional Services. Holds a Ph.D. from Newcastle University in the development of computational approaches to drug repositioning, with a focus on semantic data integration and data mining. He has been with SciBite since 2017, initially as part of the Data Science team.

• Pharmaceutical R&D Informatics

No bio available.

• Bio-IT World: Venture, Innovation & Partnering

Sean Murphy is Senior Director of Cloud Architecture for Flagship Pioneering, overseeing platform engineering for the Flagship Digital Backbone for Research Science. Sean joined Flagship from AWS, where he was Senior Life Sciences Solutions Architect. Prior to AWS, Sean was Director of Scientific Computing for the Janelia Research Campus of the Howard Hughes Medical Institute (HHMI), and Senior Software Engineer for the J. Craig Venter Institute. Sean has a PhD in Neuroscience from Yale University and undergraduate degrees in Electrical Engineering and Biology from MIT.

• Digital Biopharma

As the CEO of Vital Biosciences, Vasu Nadella oversees the vision and strategic direction of the company. Prior to starting Vital, he co-founded a machine-learning based personalization start-up which was acquired in 2018. Inovia Capital recruited Vasu where he was an entrepreneur-in-residence, focused on supporting founders in healthcare, artificial intelligence, and life sciences. In 2019, Vasu co-founded Vital. He leads a team of scientists, engineers, and diagnostics executives building the next-generation of tools and services that will enable the future of care.

• Automation, Digital Lab, and Robotics

Drazen Nadoveza received his PhD in 2014 in the Laboratory for Computer-Aided Design and Production (LICP) of the Swiss Federal Institute of Technology in Lausanne (EPFL). His major research interests include: context-aware systems, software architectures, Semantic Web, Life-Cycle Assessment and Product Lifecycle Management. Currently he works as a Tech Lead of the digital platform in the domain of the Biologics Discovery in BR.

• Digital Biopharma

Dr. Kayvan Najarian is a professor at departments of Computational Medicine and Bioinformatics, Emergency Medicine, and Electrical Engineering & Computer Science at the University of Michigan. He is currently serving as the director of Biomedical and Clinical Informatics Lab (BCIL) at University of Michigan. He is also Director of an NSF IUCRC center called Center for Data-Driven Drug Design and Treatment Assessment (DATA). Dr. Najarian is also serving as Associate Director of an institute at University of Michigan called Michigan Institute for Data Sciences (MIDAS). This institute promotes data sciences across three campuses of University of Michigan. Dr. Najarian is also serving as an Associate Director of another institute at University of Michigan called The Max Harry Weil Institute for Critical Care Research and Innovation, that focuses on designing advanced solutions in the field of trauma and critical care. The focus of Dr. Najarian’s research has been on using advanced data science techniques such as artificial intelligence (AI) and machine learning (ML) methods to design computer-assisted medical decision-making systems to improve the quality of care provided to patients and to reduce the costs of healthcare. His research work has resulted in over 350 peer-reviewed journal and conference publications as well as over 40 patents and patent applications. Dr Najarian’s team has designed AI-based decision support systems to manage complications such as heart failure, traumatic brain injury, sepsis, GI diseases and ARDS. Several technologies created by his group have been licensed to industry partners. For over the last two decades, Dr. Najarian’s research has been continuously funded by federal agencies such as NSF, NIH and DoD as well as private companies such as Janssen, AbbVie, Amgen and Toyota.

• Data Science and Analytics Technologies

Dr. Niven R. Narain is a recognized pioneer in technology development at the intersection of biology and AI. Niven developed the Interrogative Biology® platform that has unraveled actionable disease insight leading to both de novo and repurposed development of a robust pipeline of products in oncology, metabolic, rare, and CNS diseases, namely BPM 31510 currently in Phase 2 trials for cancer. These discoveries are covered by over 400 issued and pending US and international patents. Dr. Narain is a member of the NASA/Gene Lab Steering Committee and Advisor to US Department of Defense (DoD) leadership on breast and prostate cancer. He has forged strategic partnerships with industry, academia, and US and UK governments. He serves on the Advisory Board of Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Healthy Aging Initiative Commission at No. 10 for the UK Prime Minister. He is an industry thought leader in precision medicine, drug development, and AI/ML. He serves as a frequent speaker at Economist, Bloomberg, Financial Times, Wired, and Aspen Ideas as well as many international meetings on medicine and technology. In 2014, Dr. Narain was named to the Boston Business Journal top 40 leaders under 40; In 2018, he was an EY Entrepreneur of Year finalist; In 2019, he was named to the Deep Knowledge Analytics Top 100 AI Pioneers in Drug Discovery and Advanced Healthcare. Dr. Narain obtained a BS in Biological Sciences/Philosophy from St. John’s University, NY and a Ph.D. in Clinical Biochemistry with focus on Cancer Biology at the University of Miami Miller School of Medicine where he also did clinical research training in Cutaneous Oncology in the Dermatology and Cutaneous Surgery School. He later served as Director of Cutaneous Oncology Research. He has published in high impact journals with collaborators from academia, NIH, and DoD. Dr. Narain is most passionate about improving patient care and enabling increased access to innovative medicines. He is very active in educational programs for STEM in Massachusetts.

• AI for Oncology, Precision Medicine, and Health

No bio available.

• Automation, Digital Lab, and Robotics

Kimberly A. Nearing, M.S., is a Venture Partner at BVCF Management, leading U.S. investing activities including deal origination, execution, fundraising, investor relations, and portfolio management. Additionally, as Chief Business Officer for three biotech companies, she oversees business development, capital raising, and IPO campaigns, and serves as a board member for MaveriX Oncology and the RV Foundation in Washington, D.C. Kimberly has 20 years of international financial services experience in venture capital and investment banking, coupled with substantial life sciences and health tech domain experience in startups and public companies. She began her career at Amgen in BD and marketing, where she served on two product launch teams, and held an executive position at IBM Healthcare where she was elected to a 20-person team charged with developing IBM’s global healthcare strategy. Her career highlight is her global network, particularly in the U.S., Asia, and the Middle East, and cross-border deal-making experience. Her educational background includes an MSc with Honors from Harvard University, a BA in Economics with Distinction from the University of Michigan, and certificates in Healthcare AI/ML from Stanford University and Generative AI: Prompt Engineering from IBM.

• Bio-IT World: Venture, Innovation & Partnering

Jason Necaise is an Applications Developer in Professional Services at D-Wave. In his current role, Jason works with clients to design and deliver practical applications that make the best possible use of D-Wave quantum annealers to achieve tangible business value. He also engages collaborations with organizations in the quantum computing community. Jason graduated in Physics and Mathematics from MIT, where he researched topics in quantum walks and the limits to far field thermal radiation of bodies. Prior to joining D-Wave, Jason was a co-founder of qBraid, a platform for learning and developing quantum algorithms, where he worked to develop educational programs and platform interoperability between quantum hardware providers. Before that, Jason worked in the quantum applications group at IBM, where he researched optimizations in quantum chemistry simulations. He joined D-Wave in early 2021 and continues to assist the algorithms and tools development team.

• Quantum Computing

Barrie Nelson is passionate about bringing order to clinical data and clinical development processes. His BioPharma experience spans Biostatistics, Clinical Data Management, and Data Standards organizations. After spending many years as a volunteer and team lead, Barrie became the lead for CDISC standards development. Now, as a founder of Nurocor, his expertise is focused on development of the Nurocor Clinical Platform, which enables BioPharma companies to fully realize a digital clinical development process. 

• Digitization of Clinical Development and Clinical Trials

Mika Newton is an accomplished and visionary leader serving as the CEO of xCures, a prominent healthcare technology company at the forefront of personalized treatment solutions and data-driven insights. With a deep passion for improving patient outcomes and transforming the healthcare landscape, Mika Newton has steered xCures to success through strategic direction, innovative thinking, and a relentless pursuit of excellence. Under Mika Newton's leadership, xCures has secured significant funding, developed its product portfolio, and forged strategic partnerships to revolutionize the delivery of personalized medicine. With a proven track record of driving growth and fostering collaboration, Mika Newton continues to position xCures as a trusted industry leader, harnessing the power of technology and data to empower healthcare providers, enhance patient experiences, and shape the future of healthcare.

• Bio-IT World: Venture, Innovation & Partnering

Connecting with entrepreneurs and investors who are leading healthcare and life sciences into the future.

• Bio-IT World: Venture, Innovation & Partnering

No bio available.

• Knowledge Graphs

Will Oemler is the creator of Study Tracker and the Director of Software Engineering at Vesalius Therapeutics. Will has previously worked in software development & bioinformatics at Decibel Therapeutics, Blueprint Medicines, and Millennium Pharmaceuticals.

• Software Applications and Services

International marketing and business development professional with proven strategic agility and executional excellence across a broad range of therapy areas and geographies. Strong leadership and change management expertise is combined with 1st class project, alliance management, operational and entrepreneurial experience.

• Bio-IT World: Venture, Innovation & Partnering

Christian is a distinguished bioinformatics scientist known for his proficiency in infectious disease and public health, drug target selection, and drug resistance surveillance. As an integral member of the product team, Christian plays a pivotal role in shaping Dotmatics’ biologics strategy for the innovative Luma research and discovery platform, aiming to revolutionize scientists' workflow.

• Pharmaceutical R&D Informatics

Steve Pagliuca is the Chair, CEO and Founder of PagsGroup, an investment firm focused on high growth companies in tech, biotech, healthcare and the sports industry. He has played a leading role in investing in prominent tech, media, telecom and financial services businesses. PagsGroup was recently announced as a lead investor in Liquid AI, a pioneering liquid neural network technology company. In 2016, the Pagliuca Family Foundation helped create the Pagliuca Harvard Life Lab. With a focus on biotech and life sciences, the lab teams have raised $1.16 billion and incubated 59 companies. In addition, Pagliuca is the co-founder and executive chair of Arena BioWorks, a privately funded, fully independent biomedical institute. Pagliuca is a co-owner and managing partner of the Boston Celtics, president of the Shamrock Foundation and serves on the NBA Board of Governors. He is also a co-owner and co-chair of Atalanta Bergamasca Calcio, a professional football club based in Italy. Mr. Pagliuca received a B.A. from Duke University and an M.B.A. from the Harvard Business School.

• Bio-IT World: Venture, Innovation & Partnering

Abhishek leads a global machine learning team in AbbVie that deals with most of machine learning that happens in drug discovery at AbbVie. We are responsible from early discovery (target) to late discovery leading up to pre-clinical work. Broadly have team in machine learning in chemistry, machine learning in imaging/multiomics, machine learning in genomics, and machine learning advisor for AbbVie-calico alliance. In his previous life, Abhishek was founding member of machine learning team in imaging at Tempus Labs, working in field of precision medicine.

• AI for Drug Discovery and Development
• AI for Oncology, Precision Medicine, and Health

Bhavesh is an Associate Research Professor at the California Medical Innovations Institute (CalMI2), a nonprofit biomedical research institute located in San Diego, CA. He completed his Ph.D. in Mechanical Engineering at the University of California Berkeley where he specialized in computational modeling. He joined CalMI2 right after graduating in 2015 where he has been developing computational models for various organs and medical devices. He has been involved in the field of Findable, Accessible, Interoperable, and Reusable (FAIR) research practices since 2019. He started the FAIR Data Innovations Hub, a division at CalMI2 where he and his team are developing various guidelines and computer tools that make it easier for biomedical researchers to make their data and software FAIR. These includes guidelines such as the FAIR-Biomedical Research Software (FAIR-BioRS guidelines), and tools such as SODA (Software to Organize Data Automatically) for the NIH SPARC program and FAIRhub for the NIH Bridge2AI program.

• FAIR Data

Swetabh Pathak is a technology leader and innovator driving cutting-edge AI in life sciences. As the Co-Founder and CTO at Elucidata, he leads the product and technology teams. He specializes in Generative AI and LLMs. Prior to Elucidata he was a co-founder at a tech start-up and founding team member at an affordable education technology start-up. He is an alumnus of the Indian Institute of Technology Delhi (India). 

• AI for Drug Discovery and Development

David Pearlman is a computational chemistry pioneer. After receiving the first Ph.D. from UC-Berkeley focused on applying modern computational methods to study large molecules, he became the founding product manager at Biosym Technologies. He was an early employee of Vertex Pharmaceuticals, and later developed the biologics software platform for Schrodinger, Inc. Dr. Pearlman was also the first author of the AMBER program. Dr. Pearlman is VP of Product for QSimulate. 

• AI for Drug Discovery and Development

No bio available.

• Bioinformatics

As a lead IT engineer, Cristian enjoys bringing cutting-edge solutions to support the scientific instrumentations and research technology at Regeneron’s research site. He delivers high-quality, data-driven results at the Tarrytown, NY campus. Prior to his 8-year career at Regeneron, he provided technical expertise and led various projects in the pharmaceutical field. As a graduate in the field of Computer Science and Electronic Engineering, from the International Polytechnic Institute of Turin, Italy he gained global and technical skills, allowing him to pursue a career in the multifaceted world of IT.

• Automation, Digital Lab, and Robotics

Vincent Beltrani earned his bachelor’s degree in mathematics at Stony Brook University and his PhD in chemistry at Princeton University. Vincent’s research focused on computational chemistry emphasizing electronic structure theory, molecular dynamics, novel imaging techniques, and large-scale HPC calculations. At Google, Vincent has led relationships across the Healthcare and Life Sciences Industries helping customers build multi-omics platforms, solve computational drug discovery problems at an ultra-large scale, and implement AI/ML for advancing next stage therapeutics across the drug discovery process.

• Bio-IT World: Venture, Innovation & Partnering

As a servant leader and coach, I am deeply passionate about enabling teams to unleash their potential. Throughout my career, I have excelled operating at the intersection of business, technology and medicine. Extensive experience in the pharmaceutical industry, leading strategic initiatives in R&D, Finance, Informatics and Operations and having worked across various stages of the drug development lifecycle in both headquarters and affiliate settings. My expertise lies in strategic consulting, product management, agile transformation, data&analytics and digital innovation. Thriving in highly collaborative and agile environments, and I am recognized for my ability to build and inspire teams to surpass expectations in challenging environments. I am energized by experimentation and the pursuit of uncharted waters, leveraging my curiosity, integrity and passion to explore new possibilities.

• Digitization of Clinical Development and Clinical Trials

Vada A. Perkins is Vice President Global Head of Regulatory Policy & Intelligence for Boehringer Ingelheim. He is a former FDA Senior Advisor for Regulatory Science with international regulatory policy and strategy expertise in promoting convergence for the assessment of medicinal products worldwide. He received his degrees from Johns Hopkins University, University of Southern California, and the University of Maryland.

• Modern Data Platforms and Storage Infrastructure

Over 20 years in leadership, business development and sales growth in pharmaceutical, biotechnology and technology. Passionate about making a difference though innovation that can benefit humankind. Enjoy building and empowering talented teams. Former Army NCO that drives my ability to be agile and execute, as well as take on any challenge in a steadfast way. Father of three sons, which adds daily adventure to my life.

• Bio-IT World: Venture, Innovation & Partnering

Max is responsible for developing Zifo’s strategy for their Lab Data Automation Solution (LDAS) offerings.

He has over 20 years of experience in informatics and simulation technologies in life sciences, chemicals, and materials applications. He held business consulting and various technology leadership positions and managed a lab automation company. He holds a Ph.D. in Physics from Fritz-Haber-Institute of the Max-Planck-Society and a masters in physics from Technische Universität Berlin.

• Digital Biopharma

No bio available.

• Knowledge Graphs

Joseph Pickrell, PhD, is the co-founder and CEO of Gencove. With the vision of providing accessible and affordable genomic information, Gencove developed a novel low-pass whole genome sequencing and computational analysis platform for breakthrough biological discovery. Before Gencove, he was a Principal Investigator at NYGC, where his lab pioneered novel statistical approaches to transform large-scale genomic data into an improved understanding of human biology and history. 

• Digital Biopharma

Federico was born in Monza on 5/2/1996. He graduated in Automation Engineering from the Polytechnic of Milan in 2018 with full marks and honours. Federico then moved to Zurich in 2018 to study at ETH Zurich, one of the most renowned polytechnic schools in the world. He graduated in 2021 in the Master of Science in Data Science with full marks in his thesis. Federico was awarded by the Polytechnic of Milan as one of the best freshmen of the year 2016 and was ranked first out of 256 students in the Dynamic Programming and Optimal Control exam at ETH Zürich, a course to which he will contribute as Teaching Assistant the year following. After his studies, Federico founded the startup Dynius, with the mission of spreading the application of artificial intelligence in the Italian and Swiss industrial world. Dynius is now an official spin-off of ETH Zurich. Federico was Visiting Professor at the University of Bergamo in 2022 for the Economics and Business Management course.

• Quantum Computing

Dr. Plasterer has pursued interests in bioinformatics, clinical informatics, systems biology and biomarker discovery over the last twenty years in both industry and academia. He co-founded PanGenX (a Personalized Medicine/Pharmacogenetics Knowledge Base start-up), directed the project planning and data interpretation group at BG Medicine, and held an adjunct professor position in the department of Chemistry and Chemical Biology at Northeastern University. He now leads FAIR data and Knowledge Graph initiatives at AstraZeneca. In these roles at AstraZeneca, Dr. Plasterer has been responsible for establishing and executing the linked data strategy which includes knowledge representation, vocabulary & metadata services, semantic visualization, analytics and business case development. This strategy has been deployed to build the competitive intelligence and integrative informatics frameworks for R&D. Tom also serves on the Pistoia Alliance FAIR data implementation board.

• Pharmaceutical R&D Informatics

Yohann is the Sr. Director of Data Platform at Tessera Therapeutics, a genome engineering company that writes therapeutic messages into the genome to treat diseases at their source. He studied Biotechnology and Informatics in France followed by a PhD in Computational Chemistry at the University of Zurich, Switzerland. After graduating, Yohann joined PerkinElmer Informatics as a business analyst. He later joined Novartis in the Scientific Information Systems team followed by a position as head of data science at Voyager Therapeutics. Currently, as head of data engineering at Tessera, Yohann is focused on building a data platform to provide the computational environment to support the scientific team.

• Cloud Computing

Gian has over 13 years of experience in clinical data, technology, and clinical data management operations. In his current role at AbbVie, Gian is responsible for the innovation, design, and implementation of clinical technologies to enable clinical data collection, aggregation & submission. Before joining AbbVie, he had worked at Accenture, helping pharmaceutical organizations bring innovative technologies to optimize the business process.

• Data Management

No bio available.

• AI for Drug Discovery and Development

Allison Proffitt is a science writer with a background in biology and chemistry, research experience in cancer biology, and an expanding repertoire in biotech, AI, and battery chemistry. She serves as the editorial director for the Healthtech Publishing media group, a growing collection of online news sites. In addition to Bio-IT World, her work has been published by Nature Biotech, Chemical & Engineering News, and the Economist Intelligence Unit. She has a bachelor’s degree in communication of science, engineering, and technology from Vanderbilt University and a Master’s degree in science and medical writing from Johns Hopkins University.

• AI for Drug Discovery and Development
• Generative AI
• AI for Oncology, Precision Medicine, and Health
• Bioinformatics
• Cloud Computing
• Data Science and Analytics Technologies
• Pharmaceutical R&D Informatics
• Software Applications and Services
• Modern Data Platforms and Storage Infrastructure
• Data Management

As COO of R&D, Imogen Pryce manages all operational aspects of R&D, from budgeting to recruiting to program and portfolio management, with a focus on optimizing the value of the portfolio. Prior to joining Relay Therapeutics, Imogen worked in corporate strategy at Shire Pharmaceuticals. There, she managed and contributed to multiple projects ranging from whole company initiatives to targeted efforts within specific therapeutic areas and functions. Prior to joining Shire, Imogen worked at Boston Consulting Group, where she was a leader in the healthcare practice area. She advised senior client teams on a number of topics, including corporate strategy, M&A due diligence, and R&D portfolio prioritization. Imogen holds a B.S. from the Ohio State University and a Ph.D. in chemical engineering from the California Institute of Technology.

• Bio-IT World: Venture, Innovation & Partnering

Fotis Psomopoulos, Eng, PhD, is a Researcher at the Institute of Applied Biosciences (INAB), at the Centre for Research and Technology Hellas (CERTH), in Thessaloniki Greece. He holds a PhD in Electrical and Computer Engineering with a focus on Bioinformatics. His research interests lie at the intersection of Bioinformatics and Machine Learning, primarily working on the design and implementation of data mining algorithms for knowledge extraction from large datasets in Life Sciences. In this context, he was selected to be an EGI Champion on Life Sciences in 2013, an RDA-EU Ambassador for Bioinformatics in 2019, and he is currently co-leading the ELIXIR Machine Learning Focus Group. In addition to his research activities, he is particularly active in training efforts and initiatives (such as the Carpentries and GOBLET). He is the Training Coordinator of ELIXIR-GR, a member of the ELIXIR Training Platform Executive Committee, and was the National representative for the EOSC Skills and Training Working Group. Finally, he is a strong advocate of Open Science; he is a co-author of the Open Science Training Handbook and the Greek National Plan for Open Science, and an active mentor in the Open Life Science programme.

• FAIR Data

No bio available.

• Quantum Computing

Santha is passionate about the effective use of data and enabling organizations for it, via strategy, people, technology and operations. Her experience in life science R&D, informatics and data comes from leading R&D data strategy and operations at Sanofi, developing informatics products at Monsanto, Ingenuity and Certara, managing business units in Jubilant Biosys and advising and enabling pharma clients at Deloitte.

• Data Management

Brigitte Raumann is a Product Manager at Globus and led the effort to enable Globus support for management of protected research data, including PHI and CUI. As the Globus Privacy Officer, she continues to oversee the Globus compliance program and incident investigations. Brigitte has focused her career on providing researchers with the software tools and data they require to advance discovery. Her decades of experience span sectors as diverse as biotech, publishing, patent law, and academic clinical research. Brigitte Raumann earned her B.A. from the University of California, Berkeley and her Ph.D. in biochemistry from the Massachusetts Institute of Technology.

• Automation, Digital Lab, and Robotics

Dr. Kamal Rawal is an interdisciplinary professional with extensive experience in machine learning and bioinformatics. He has successfully executed large-scale complex projects such as Semi-Automated Text Mining System, an AI-based Vaccine Discovery System; Next-Generation AI-based Cancer Diagnostic System, & AI-Driven Obesity and Diabetes Management System. Currently, he is working as a Project Director on an International project. Concurrently, he holds an Associate Professor position in one of the leading universities and mentors several AI-based startups.

• AI for Oncology, Precision Medicine, and Health

Did her Masters in Biotechnology and Ph.D. in the field of Virology and Immunology at the All India Institute of Medical Sciences, New Delhi. As Link Person in the Indo-UK Higher Education Link Programme between the Paterson Institute of Cancer Research, Manchester, UK and the All India Institute of Medical Sciences, New Delhi, she worked on antibody engineering and Phage Display Technology during 1995 to 2000. She was awarded the Young Scientist Award by the Indian Immunology Society in 2000, and the Young Scientist Fellowship by the Department of Science and Technology, Government of India in 2001. While at AIIMS, she worked on developing rapid diagnostic tests for typhoid, rabies immunotherapy and dendritic cell biology in relation to zinc deficiency. She joined the National Institute of Virology, Pune in 2005 and helped set up and headed the Avian Influenza Division at NIV in response to the first outbreak of Avian Influenza in India in 2006. The Avian Influenza laboratories were awarded the status of WHO Regional Reference Laboratory for H5N1 in Southeast Asia in March 2008 by the World Health Organisation (WHO). Dr. Ray was part of the core group of scientists at the Microbial Containment Complex, NIV, responsible for work carried out in the BSL 3+ laboratories. She worked as Scientific Consultant to the Chairman, Apollo Hospitals Educational and Research Foundation, Delhi during 2008-2010 with special emphasis on developing capacity for carrying out stem cell research. She has been active in the areas of social welfare and justice particularly in rights based issues of gender justice and equality, rural employment, food security, education, health, rights of the elderly and judicial accountability for the last ten years which took her out of active scientific research into a more direct involvement with programmes and people on the ground. Dr. Ray joined OHSL in 2018 and is overseeing biomedical research at OHSL through collaborative scientific programmes and consortia. Her research interests lie in the areas of Ayurveda and cancer, immunotherapy, engineered antibodies and phage display libraries. She believes in creating a platform where young scientists and students can bring their ideas and where a support system of mentorship, collaboration and infrastructure can be built around them to further their research goals.

• AI for Oncology, Precision Medicine, and Health
• Bioinformatics

Ronald has extensive experience in lab informatics, lab automation and microtiter plate-based assays from working at Rockefeller University, Columbia University and a start-up biotech company, Therasis. He holds a degree in Science Informatics with a Concentration in Molecular Biology from Montclair State University and a Master of Science degree for Information and Knowledge Strategy from the Columbia University School of Professional Studies. Ronald is responsible for development of a bioassay data management platform for scientists at Regeneron. Ronald excels at communication of organizational goals to facilitate collaboration and he is also skilled in building information management systems that lead to downstream applications that enable data-driven decisions and insight.

• Modern Data Platforms and Storage Infrastructure

Anupama Reddy is Co-Founder and COO of Vindhya Data Science. Anupama has a deep background in computational biology, genomics, and machine learning. As a member of Translational Bioinformatics in Oncology at Novartis Institutes for Biomedical Research, she was a co-author of the Cancer Cell Line Encyclopedia, a seminal publication in the field of Oncology. Her next role was at Duke University where she was a bioinformatics group leader and played a key role in multiple cancer genomics and drug discovery projects. Anupama has published over 50 peer-reviewed articles in high-impact journals such as Cell and Nature. Her work has also resulted in 2 US patents. Anupama holds an MS and a PhD from Rutgers University.

• Digitization of Clinical Development and Clinical Trials

With 19 years in pharmaceuticals, Bhargava Reddy is Head of Advanced Insights at J&J Innovative Medicines. He drives operational efficiency through analytics solutions, fostering collaboration and innovation. Previously, he led Advanced Analytics at UCB, focusing on machine learning for clinical decision making. Bhargava holds a Ph.D. from Oklahoma State University, an MS from Northwestern University, and has published methodology papers on machine learning and deep learning in peer-reviewed journals.

• Generative AI

Sreeni Reddy, a global tech visionary in Lifesciences, drives strategy and fosters innovation in AI, data science, and analytics. His breakthroughs include AI-driven automation for COVID vaccines, NLP models for trials, and advanced AI solutions in Pharma R&D.

• Generative AI

Valentine Reid joined Flagship Pioneering in July 2023 as Director of Cloud Operations. Valentine has spent 17 years in technology, including 4.5 years at AWS where he advised Healthcare and Life Science customers of all sizes on Cloud Operations and Security Architecture. At Flagship Valentine is responsible for implementing solutions that allow business to achieve transformational outcomes on cloud.

• Cloud Computing

Philippe Rocca-Serra graduated from the Ecole Nationale Supérieure d'Agronomie de Rennes, France with a Diplôme d'Ingénieur before completing a PhD in Molecular Genetics from the University of Bordeaux (2001), during which he was supported by EMBO fellowship supporting collaboration the University of Oslo. He then joined the EMBL European Bioinformatics Institute (EBI), contributing to the design and development of databases, tools, and data standards for communicating scientific results generated by Omics technologies. He joined the Oxford e-Research Centre in 2010 and has continued developing his activities on open data and open science.

• FAIR Data

Dr. Jeffrey Rosenfeld, PhD, MBA has extensive experience in genomics and bioinformatics. He is the author of over 40 scientific publications, a graduate-level textbook, and the recipient of a US patent. He received his undergraduate education at the University of Pennsylvania and his PhD in biology from NYU. He performed his doctoral research at the prestigious Cold Spring Harbor Laboratory. Over his 15-year career in genomics, he has worked on a wide range of biological and genetic projects including genetic association studies of schizophrenia, genomic testing of embryos for fertility treatments, gene patent litigation, and clinical cancer genome sequencing. For the past five years, he has been an Assistant Professor of Pathology and Laboratory Medicine and the head of the Bioinformatics Core at the Rutgers Cancer Institute. In this role, he has become very familiar with laboratory testing both for cancer and other genetic diseases. He has set up the computational infrastructure for multiple tumor sequencing panels as well as a clinical data warehouse. Dr. Rosenfeld is always at the leading edge of technology and is looking for the newest ideas that can be used for scientific research and diagnostics including single-cell techniques and long-read sequencing. Additionally, Dr. Rosenfeld has been sought out for his expertise as the head of Rosenfeld Consulting LLC. Clients come to him seeking advice regarding genomics, oncology, and laboratory testing. Due to his long tenure in the field and his knowledge of genomics as well as finance, he can give a clear assessment of the companies and their potential. Companies approach Dr. Rosenfeld looking for his expert-level genomics knowledge, industry insight, and management experience.

• Bioinformatics

Jami Rubin has 30 years of experience in the biopharma industry as a finance executive, equity analyst, investment banker, board member, and venture partner. Prior to Boundless Bio, she served as Chief Financial Officer of EQRx where she built a world-class finance organization and led a transformational go public process that raised $1.35 billion. Previous to EQRx, Jami was a Partner at PJT Partners, a global advisory-focused investment bank, where she provided strategic M&A, corporate finance, and capital-raising guidance for biotech and pharmaceutical companies. She also served as a Partner at Goldman Sachs where she led the healthcare business unit and ranked as a top pharmaceutical industry analyst. Earlier in her career, Jami was Managing Director at Morgan Stanley where she covered large cap and specialty pharma. Jami is a Venture Partner at ARCH Venture Partners and a member of the Board of Directors and audit committee chairperson of Relay Therapeutics.

• Bio-IT World: Venture, Innovation & Partnering

Terrell Russell currently serves as Director of Data Management for RENCI and provides management, oversight, and high level architecture design for the iRODS Consortium. He's interested in distributed systems, metadata, security, and open source software that accelerates science. Terrell holds an M.S. in Computer Networking from North Carolina State University, and a Ph.D. in Information Science from the University of North Carolina at Chapel Hill.

• Data Management

Wasim Sadar is currently a Sr. Project Manager for Research and Pre-Clinical Development IT at Regeneron focusing on enabling science through technology solutions for multiple Therapeutic Focus Areas. Wasim has over 25 years of experience in Technology, is versed in all major project delivery methodologies and has a particular focus in UX (User Experience). Wasim has formal degrees (AAS, BBA, MS) and acquired multiple certifications to support and reinforce his career path including PMP, CSM, CPO, SaFE,, Six Sigma Green Belt and several other IT certifications. After joining Regeneron Wasim's focus has been primarily Streamlining Experimental Data Capture with Researchers while conducting their in vivo experiments within the Vivariums. He has been instrumental in researching, testing, deploying and training researchers in adopting various technologies deployed over the last 4 years. He continues to focus on bringing in new technologies such as XR (Mixed and Virtual Reality) headsets to support and train users, voice interactive workflows and automating animal identification Creating and driving solutions with vendors and business partners to improve the scientific experience.

• Automation, Digital Lab, and Robotics

Hugh Salamon is a strategic thinker with 25 years' leadership experience in bioinformatics and computational biology. Hugh has worked in Pharma and non-profit research, served as a consultant, and co-founded a contract data analysis company. He invented a powerful gene set analysis method that is simple, fast, captures reproducible findings and accommodates nestable, sets-of-sets, computations. Hugh recently served as Scientific Director of Bioinformatics within Scientific Strategy at Exelixis, where he led a FAIR-compliant platform build, data integration, and Real-World Data (RWD) analysis focused on delivering tumor and tumor microenvironment drug targets and patient selection strategies. He is currently consulting on FAIR-compliant computing to Nebulaworks, on AI-readiness for scientific data and documents, and contributing to engineering LLM-driven systems that preserve scientific accuracy.

• Data Science and Analytics Technologies

Proteomics and Mass Spectrometry Scientist at Regeneron Pharmaceuticals located in Tarrytown NY for more than 15 years. Team leader for Immunopeptidomics (Discovery and Targeted) for oncology, infectious disease and autoimmunity.

• Pharmaceutical R&D Informatics

Since 2001, Susanna operates in the area of data interoperability, research integrity, and the evolution of scholarly publishing, working with and for researchers, service providers, journal publishers, library science experts, funders, and learned societies in the academic as well as in the commercial and governmental setting. With her Data Readiness Group (https://datareadiness.eng.ox.ac.uk), at the University of Oxford, she: (i) enables science by investigating and implementing methods, standards and tools to improve data curation and publication; (ii) influences data policies by leading and promoting guiding principles for data management and stewardship to support data reuse; (iii) prepares the new generation of scientists by creating and delivering educational material, to address the glaring lack of courses in these specialized subjects. An author of the FAIR Principles, Susanna has initiated and participated in a variety of community activities across disciplines, including: founder of the Nature's Scientific Data journal, member of several Boards of Directors (e.g. Dryad, Centre of Open Science) and formal standardization groups (e.g. ISO TC/276, EOSC FAIR Metrics and Data Quality Task Force). In the context of ELIXIR, she a co-lead of the ELIXIR Interoperability Platform (https://elixir-europe.org/platforms/interoperability).

• FAIR Data

Anamika joined Regeneron Pharma in 2017 and currently the Lead of Intelligent Automation group in Global Development Solutions. Prior to Regeneron she worked at Paragon Solutions (currently CGI) where she was strategy consultant in Clinical and Regulatory Operations spaces for both Biotechs and CROs. Some of her past experience in consulting includes as IT consulting role at Daiichi Sankyo Pharma and Domain Consultant for big pharma companies at Wipro Technologies. She is passionate about bringing right drug to right patient. Anamika is a PhD and MBA (Pharma Industry Management from Rutgers University), who started her scientific career as Computational Biologist, after her PhD, in the same field, from IITD (Indian Institute of Technology Delhi, India). She has worked as scientist both in academia (University of Washington Seattle, Memorial Sloan Kettering Cancer Center, Mt. Sinai School of Medicine) as well as pharma industry (Novartis, Inc.). She had been consulting as a bridge between business, technology, and science since 2012 'til she joined Regeneron in 2017.

• Automation, Digital Lab, and Robotics

Dr. Sarver is a Director in ZS Discovery at ZS Associates, where he uses his experience in academia, biotech, and pharmaceuticals to assist global companies with answering challenging R&D questions. He has worked with a variety of cross-functional teams composed of statistical geneticists, bioinformaticians, computational biologists, and disease specialists. Dr. Sarver frequently acts as a bridge between scientific- and technology-focused teams to deliver impact across the pharmaceutical pipeline.

• AI for Oncology, Precision Medicine, and Health

Miruna Sasu currently serves as President and CEO at COTA Inc., an innovative oncology real-world data and solutions company. She is known for developing technology companies with a deep focus in understanding life science/drug development value drivers and aims to advance complex objectives that help lengthen and enhance human lives. In 2023, Miruna was awarded the MedTech Breakthrough award for ‘Best MedTech CEO’. In 2022, she was recognized as one of the top 25 women leaders in biotechnology for her trailblazing work in the invention and application of innovative next-generation solutions to solve tangible problems across a variety of healthcare industry sectors. In past roles, Miruna has led organizations at Johnson & Johnson and Bristol-Myers Squibb, where she revolutionized company-wide use of technology for minimizing cost of drug development, use of real-world data for faster drug development, and application of data sciences across enterprise drug portfolios from drug discovery all the way to commercialization and post-marketing. Miruna holds a Ph.D. in biology and statistics from Penn State University and an MBA from Temple University.

• Bio-IT World: Venture, Innovation & Partnering

Sebastian Scharf is a Data Scientist with a passion for Data FAIRification, integration and visualization.

• Knowledge Graphs

Mike has worked extensively in target ID biology and drug discovery at Novartis Oncology and KSQ Therapeutics. His role at Curie Bio is to identify promising ideas and founders and help them achieve their goals of making great therapies to benefit patients.

• Bio-IT World: Venture, Innovation & Partnering

Sebastian Schlicker has more than 15 years of experience in managing pharma R&D IT projects, specializing in the implementation of global enterprise software solutions for large molecule R&D. As the director of Genedata’s Biologics business, Sebastian oversees all major consulting and deployment projects globally. Currently based in Basel, Switzerland, Sebastian previously worked out of the Genedata Boston office, where he helped to build Genedata’s biopharma business in the US. Among his many responsibilities, he led implementation and customization projects for major US biopharma companies. Before joining Genedata, Sebastian worked at Sanofi, where he managed the implementation of new R&D platforms in both small- and large-molecule R&D, covering the complete project life-cycle and resulting in integrated and harmonized enterprise solutions used by scientists around the globe. Sebastian holds a degree in Computer Science and Economics from the University of Applied Sciences in Darmstadt, Germany.

• Digital Biopharma

Sebastian has 20 years of experience in the IT industry, throughout which he has held leading positions in software engineering, pre-sales, consulting and product management. As CEO at metaphacts, Sebastian leads customer- and partner-facing activities and is responsible for driving digital transformation initiatives with customers across Europe, North America and Asia.

• Data Management

Dr. Schulz is an Assistant Professor of Laboratory Medicine and computational health care researcher at Yale School of Medicine. He received his PhD in Microbiology, Immunology, and Cancer Biology and MD from the University of Minnesota. He is the Director of Informatics for the Department of Laboratory Medicine and Medical Director of Data Science for Yale New Haven Health System. Dr. Schulz has over 20 years’ experience in software development with a focus on enterprise system architecture and has a research interests in the management of large, biomedical data sets and the use of real-world data for predictive modeling. At Yale, he has led the implementation of a distributed data analysis and predictive modeling platform, for which he received the Data Summit IBM Cognitive Honors award. Other projects within his research group include computational phenotyping and the development of clinical prescriptive models for precision medicine initiatives. His clinical areas of expertise include molecular diagnostics and transfusion medicine, where he has ongoing work assessing the use, safety, and efficacy of pathogen-reduced blood products.

• Knowledge Graphs

Matt Schulze is a Senior Director in the Flagship Digital, IT, and Informatics team, where he leads and manages the digital evolution for Pioneering Medicines (PM). His role is pivotal in ensuring that digital strategies align with the overall goals and objectives of the Flagship Pioneering Initiative. Matt's team is dedicated to delivering value through digital technologies for and alongside PM's functional teams. With an extensive background in digital life sciences, Matt's expertise spans applications, informatics, data management, and IT/OT management. He previously led Digital Biomanufacturing Applications at the Arch-backed CDMO start-up, Resilience. There, he built a team that implemented global manufacturing automation systems, Quality Assurance applications, laboratory systems, and data management applications. Before his tenure at Resilience, Matt spent time working at Bristol-Myers Squibb, Genzyme, Sanofi, and Alkermes. In these roles, he designed and developed laboratory informatics for Quality Control, CMC, and R&D teams. Matt holds a B.S. in Biology and Biotechnology from Worcester Polytechnic Institute and an M.B.A. from the Boston University Questrom School of Business, where he focused on Strategy and Innovation.

• Software Applications and Services

Jay Schuren is a technical business leader who has partnered with Fortune 500 companies across industries to develop and deploy thousands of AI/ML models. Schuren formerly served as DataRobot’s Chief Data Science Officer where he drove organizational transformation across multiple internal and customer facing teams. Schuren joined DataRobot in 2017 as part of the acquisition of Nutonian and co-developed the company’s industry-leading time series forecasting solution. He has a Ph.D. in Mechanical Engineering with a concentration in Applied Engineering Physics from Cornell University. Presently, Jay is leading a cross-functional initiative aimed at closing the confidence gap with Generative AI.

• Data Management

No bio available.

• Software Applications and Services

No bio available.

• Bioinformatics

Anu Sharma is a Principal Scientist and Real-World Evidence Platforms leader at Merck. She leads Data Sciences, Platform Strategy and Health Economic Modeling Initiatives within the Center for Observational and Real World Evidence (CORE) working with cross functional teams to leverage the value of real world data across the drug discovery, clinical development and commercialization lifecycle. Anu is a STEM leader, an AI enthusiast and avid industry speaker. With multiple accolades, she continues to strive towards saving patient lives and making world a healthier place.

• Generative AI

Chris is a senior analyst and managing director in equity research at Goldman Sachs covering the Pharmaceuticals and Biotechnology industries. Chris began his career in equity research at Hambrecht & Quist covering biotechnology, medical device, and life science tools companies. He then was the senior analyst covering the US major pharmaceuticals sector and global coordinator at JPMorgan. He was subsequently a portfolio manager with UBS O'Connor and an analyst with Pioneer Investments, then was a senior biotechnology analyst and managing director at Cowen, before joining Goldman Sachs in 2021. Chris earned a BA in Biology from Harvard University in 1985, an MD from Columbia University College of Physicians and Surgeons in 1989, and an MBA from Columbia Business School in 1997. He completed his medical internship at Columbia in 1990, residency in Anesthesiology and Critical Care Medicine at the Massachusetts General Hospital in 1993, and was a board-certified member of the clinical faculty of Cornell Medical College and a clinician at Memorial Sloan Kettering Cancer Center from 1993 to 1998.

• Bio-IT World: Venture, Innovation & Partnering

With over 25 years of experience in computational chemistry and informatics, Bill is an accomplished leader and innovator in drug discovery. He is the Executive Director of Structural Biology and Chemistry at Gilead Sciences, a leading biopharmaceutical company that develops and delivers life-saving medicines for patients with unmet medical needs. Bill leads a team of researchers who maintain and analyze chemical and biological data, and develop applications to support workflows within the department. He is also responsible for designing, developing, and deploying new solutions using chemoinformatics tools and AI to enhance decision making in drug discovery. Bill has a PhD in Chemistry (Chemical-Physics) from Wesleyan University and has a proven track record of applying structure-based design and small molecule computational modeling to various projects, resulting in multiple patents and publications. He is also the founder of Imaginary Consulting, a scientific and business consulting firm that serves various clients in the life sciences industry. Bill's mission is to use his expertise and creativity to augment human intelligence and improve the quality and speed of drug discovery.

• Digital Biopharma

Dr. Joe Shonkwiler is a seasoned physician executive and brings a diverse skill set encompassing clinical medicine, digital health ventures, business development, health policy, and clinical outcomes research. As the inaugural Chief Operating Officer at ARPA-H, he oversees all business operations for the agency. Before assuming his role at ARPA-H, Joe played a pivotal role in the healthcare and life sciences arena. During his tenure at Amazon Web Services (AWS), he supported biotech, healthtech, and medtech investors, guiding portfolio companies from seed to exit. His expertise enabled these ventures to accelerate their scientific and engineering endeavors, navigate technical and regulatory challenges, and achieve rapid market entry. Notably, he served as the creator and host of the AWS Health Innovation Podcast, featuring leading healthcare and life science entrepreneurs and investors. Joe's entrepreneurial journey saw him serve as the CEO of a healthcare software startup, emerging from Columbia University's Department of Surgery. Furthermore, he navigated the dynamic landscape of tech-enabled healthcare services as a Vice President at Aledade, a venture-backed startup. At Aledade, Joe spearheaded the nationwide implementation of population health management software and practice transformation services. His role extended to providing ongoing training for internal and external stakeholders. Additionally, he co-hosted and co-created a podcast focused on the emerging world of value-based healthcare.His impactful journey includes a senior advisory position in the United States Senate, helping shape healthcare policies. His rich career reflects a steadfast commitment to advancing healthcare, seamlessly integrating clinical expertise, research acumen, and strategic business leadership.

• Bio-IT World: Venture, Innovation & Partnering

R&D Data & Analytics Data Product Manager - Global Biometrics Data Sciences: Passionate about solving problems that impact patient lives. Sixteen years of experience helping conceptualize & build data & analytics solutions to deliver a variety of use cases within the area of Drug Development Data Sciences, Clinical Trial Design, Clinical Data Management, Clinical Analytics, Trial/Site Feasibility, Safety, Clinical Operations, Clinical Data Repository (CDR), Metadata Repository (MDR), Statistical Computing Environment.

• Data Science and Analytics Technologies

Experienced in data storage strategy including security data management. Have undertaken multiple initiatives to position data as an asset from liability.

• Cloud Computing

Abhinava brings over a decade of experience in technology, specializing in spearheading large-scale, cross-functional tech programs. With a deep focus on the Healthcare & Pharmaceutical sectors, he has successfully designed and developed various data management products and solutions, encompassing R&D, Real World Evidence, Clinical Trials, and Customer-Centric Marketing. As an experienced Machine Learning (ML) architect, Abhinava has a track record of scaling data science models into comprehensive ML solutions, collaborating effectively with data scientists, engineers, and business teams. Additionally, he is proficient in integrating General AI (Gen AI) technologies to enhance decision-making and operational efficiency.

• Generative AI

Ted Slater is Managing Principal, Scientific Informatics Consulting at EPAM, focusing on healthcare and life sciences. He has held senior roles at Pfizer, Merck, Elsevier, and biotech startups. A co-author of the FAIR Guiding Principles for scientific data management, he applies knowledge engineering and AI to pharmaceutical R&D. He holds an M.A. in Molecular Biology from the University of California, Riverside, and an M.S. in Computer Science from New Mexico State University. He is based in Northwestern Lower Michigan.

• Software Applications and Services

Dr. Christopher Southan works at the interface between bioinformatics, cheminformatics, pharmacology and drug discovery. His current role as Data Scientist at Medicines Discovery Catapult, UK (working remotely from Sweden) was preceded by being Principle Consultant at TW2 informatics in Göteborg, Sweden. In turn this was preceded by Senior Cheminformatian for the Edinburgh University BPS/IUPHAR Guide to Pharmacology database team 2013-18. Prior to this he set up TW2Informatics, engaging in patent data consulting for SureChem (2011-12) and the AstraZeneca Knowledge Engineering Program for testing and documenting Chemistry Connect (2009-11). During 2008-9, he coordinated the ELIXIR Database Provider Survey at the EBI, preceded by a Principle Scientist and Bioinformatics Team Leader position in AstraZeneca, Mölndal (2004-7) preceded by senior bioinformatics positions at Oxford Glycosciences Gemini Genomics and SmithKline Beecham. He has a PhD in Protein Chemistry from the Ludwig Maximillian University of Munich and a BSc Hons in Biochemistry from Dundee University (further information on LinkedIN).

• Bioinformatics

Dan serves as a Global AI Cloud Director for Healthcare & Life Sciences and leads Oracle Cloud’s partnership with NVIDIA for healthcare, aligning a life-long love of cutting-edge technology, with a passion for  transforming healthcare. He  has led engagements with many of the biggest names in healthcare and AI, creation of Oracle’s first health data fabric solution and collaborations  including for genomic analysis. Previously,  Dan founded and led a tech company for 20 years. Follow him on LinkedIn.

• Cloud Computing

Parthiban Srinivasan, an experienced data scientist, earned his PhD from Indian Institute of Science, specializing in Computational Chemistry. After his PhD, he continued the research at NASA Ames Research Center (USA) and Weizmann Institute of Science (Israel). Then he worked at AstraZeneca in the area of Computer Aided Drug Design for Tuberculosis. Later, he headed informatics business units in Jubilant Biosys and then in GvkBio before he floated the company, Parthys Reverse Informatics and later an AI consultancy, Vingyani. Currently, he is a Professor at Indian Institute of Science Education and Research (IISER) Bhopal, teaching Data Science.

• W1: Generative AI 101: Demystifying for Drug Discovery Research

Anil Srivastava as head of Open Health Systems Laboratory (OHSL) located on the JHU Montgomery County Campus at US National Cancer Institute (NCI) in Rockville, MD, leads the ICKA: International Cancer Knowledge Alliance and ICTBioMed: International Consortium for Technology in Biomedicine beside serving as Special Volunteer, Radiation Research Program (RRP) and Member, Quantitive Imaging Network (QIN) International Liaison Committee at NCI. In the past, he has worked as an international program coordinator with NCI’s Center for Biomedical Informatics and Information Technology (NCI CBIIT) where he led the IUCRG: Indo-US Cancer Research Grid initiative which led to the creation of the National Cancer Grid in India. Later he served as senior advisor for life sciences with Internet2 (University Corporation for Advanced Internet Development) and Advisor to India’s National Knowledge Commission which established the direct fiber connection between the research and education network of India (National Knowledge Network) and United States (Internet2). He currently serves as Advisor, Biomedical Informatics for the Indian National Cancer Institute of the All India Institute for Medical Sciences (AIIMS), New Delhi, and Visiting Faculty and Consultant on Information Technology for Tata Memorial Hospital, Mumbai, India. As part of the collaboration between OHSL and Tata Memorial Hospital he advised on international procurement of the proton therapy facility and planning for the center of excellence and research for carbon ion therapy. He has been associated with the conception and planning of the Indian National Cancer Institute of AIIMS from the beginning. Previously, he was a member of Apple’s Advanced Technology Group. He continues his work as Advisor to the World Bank Group increasingly focusing on health systems and planning for non-communicable diseases treatment and research in LMICs (Lower and Middle Income Countries). In the past, he worked as a senior professional advisor with Booz-Allen & Hamilton in the Asia-Pacific region. He has several publications and research papers to his credit and has been a speaker at professional conferences (AACR, Accelerating Biology Symposium, BioIT, Indian Cancer Congress, Internet2, etc.). Biomedical informatics and establishing international collaboration in cancer research and treatment are his special field of interest and expertise. Prior to moving to the United States, he was the founding chief executive (1989-91) of NASSCOM: National Association of Software and Service Companies and founding director (1972-86) and head of Knowledge Engineering with Centre for Development of Instructional Technology.

• AI for Oncology, Precision Medicine, and Health
• Bioinformatics

Dr. Eric Stahlberg now directs cancer data science initiatives at the Frederick National Laboratory, having led and launched several initiatives at the lab. He has been instrumental in establishing the Frederick National Laboratory’s high-performance computing initiative and in assembling scientific teams across multiple, complex organizations to advance predictive oncology. Stahlberg first joined the Frederick National Laboratory in 2011 to form and direct the National Cancer Institute’s Center for Cancer Research Bioinformatics Core, which helped build intramural research collaborations between the national laboratory and the National Cancer Institute. Since then, Stahlberg has played a leadership role in many key partnerships, including a major collaboration between the National Cancer Institute and the Department of Energy. Under the Joint Design of Advanced Computing Solutions for Cancer (JDACS4C), the National Cancer Institute and Department of Energy are accelerating progress in precision oncology and computing. The collaboration is rooted in three major national initiatives; the Precision Medicine Initiative, the National Strategic Computing Initiative, and the Cancer Moonshot. He has helped lead initiatives to transform data management approaches at the lab as well as more recently leading program efforts exploring the application biomedical digital twins for cancer applications. Stahlberg has spearheaded the Frederick National Laboratory’s contributions to a number of JDACS4C projects, including ATOM and CANDLE. He helped launch the annual meeting series, Frontiers in Predictive Oncology and Computing, and co-organizes the annual Computational Approaches for Cancer and HPC Applications of Precision Medicine workshops. In 2017, he was recognized as one of FCW‘s Federal 100. Stahlberg holds a Ph.D. in computational chemistry from The Ohio State University.

• AI for Drug Discovery and Development
• Generative AI
• AI for Oncology, Precision Medicine, and Health
• Bioinformatics
• W6: Biomedical Digital Twins
• Pharmaceutical R&D Informatics

Dr. Dan Stanzione, Associate Vice President for Research at The University of Texas at Austin since 2018 and Executive Director of the Texas Advanced Computing Center (TACC) since 2014, is a nationally recognized leader in high-performance computing. He is the principal investigator (PI) for several projects including a multimillion-dollar National Science Foundation (NSF) grant to acquire and deploy Frontera, which will be the fastest supercomputer at a U.S. university. Stanzione is also the PI of TACC's Stampede2 and Wrangler systems, supercomputers for high-performance computing and for data-focused applications, respectively. He served for six years as the co-director of CyVerse, a large-scale NSF life sciences cyberinfrastructure in which TACC is a major partner. In addition, Stanzione was a co-principal investigator for TACC's Ranger and Lonestar supercomputers, large-scale NSF systems previously deployed at UT Austin. Stanzione received his bachelor's degree in electrical engineering and his master's degree and doctorate in computer engineering from Clemson University, where he later directed the supercomputing laboratory and served as an assistant research professor of electrical and computer engineering.

• AI for Drug Discovery and Development
• Generative AI
• AI for Oncology, Precision Medicine, and Health
• Bioinformatics
• Cloud Computing
• Knowledge Graphs
• Data Science and Analytics Technologies
• FAIR Data
• Quantum Computing
• Pharmaceutical R&D Informatics
• Software Applications and Services
• Modern Data Platforms and Storage Infrastructure
• Data Management
• Automation, Digital Lab, and Robotics
• Digital Biopharma
• Digitization of Clinical Development and Clinical Trials

Andreas Steinbacher has a background in mechatronic engineering and a PhD in Physics. Before pursuing his academic career, he worked on enhancing measurement and regulation systems for large-scale chemical production sites. During his undergraduate studies, he explored the field of biophysics and specialized in spectroscopic method development and automated data analysis within analytical and physical chemistry during his PhD and postdoctoral roles. His academic endeavors paved the way for his transition to the pharmaceutical industry, joining Roche Pharma Research and Development (pRED) where he spearheaded digitalization in research laboratories and successfully implemented a digital lab automation platform. Currently, Andreas is applying his expertise to address preclinical data management challenges at Novo Nordisk by creating new digital solutions for Entity Registration Systems, Research Sample Inventories, and ELNs & LIMSs. He also works with Data Scientists and Researchers to develop innovative strategies and methods that advance data-driven drug discovery.

• Automation, Digital Lab, and Robotics

Grigoriy is a Senior Principal Engineer on the Data Platform team at Tessera Therapeutics. After graduating with a Master's degree in Computer Science in 2010, he worked in various software and data engineering roles in pharma/biotech over the next 13+ years. First, creating multiple data analysis applications for Novartis Institutes for Biomedical Research, later, as a Principal Software Engineer at the Broad Institute of MIT and Harvard where he helped improving the open-source Cromwell workflow engine. At Tessera Therapeutics Grigoriy is responsible for design and implementation of scalable pipeline infrastructure.

• Cloud Computing

No bio available.

• FAIR Data

Jon Stevens is the AI-Language Capability Lead on AbbVie's RAIDERS team and a founding member of a new team dedicated to bringing generative AI solutions to the enterprise. He received his PhD in Linguistics in 2013 from the University of Pennsylvania, after which he worked as a researcher in computational linguistics and cognitive science for five years before joining AbbVie as an NLP Engineer in 2018. When he is not harnessing the power of language models, Jon enjoys playing video games with his family and noodling on the banjo.

• Knowledge Graphs

No bio available.

• Software Applications and Services

Aleksandar currently leads the Translational Data Engineering and Solutions team within Johnson & Johnson Innovative Medicine Data Science Solutions, Privacy & Ethics group. The mission of the team is to manage and organize Janssen’s translational data over the entire therapeutic development cycle and to deliver innovative platforms and solutions that utilize this data to contribute towards effective and timely portfolio decisions. Before establishing his team, Aleksandar worked as a computational research scientist within Janssen’s Immunology Therapeutic Area, supporting bench scientists to develop hypotheses about disease mechanisms, novel therapeutic targets, biomarkers, and combination therapies using molecular networks derived from human data collected as part of clinical trials. Prior to joining Janssen in 2013, Aleksandar was a Visiting Fellow and Research Fellow at the National Center for Biotechnology Information (NCBI) in Bethesda, Maryland, where he focused on developing theoretical frameworks and computational tools for biological network analysis. He earned his Ph.D. in mathematics at Victoria University of Wellington, New Zealand, focusing on theory of similarity search of high dimensional datasets and its applications to short peptide fragments. He is an author of 32 peer-reviewed publications and won three Johnson & Johnson Innovation Leadership Awards as well as a 2021 Spark Innovation Award.

• Data Management

Chris Stumpf is a Senior Principal Marketing Professional responsible for Signals Research Suite and Spotfire Product Marketing at Revvity Signals Software, Inc.  Chris has over 20 years of experience in the Analytical Instrumentation and Informatics industry spanning Pharmaceuticals & Life Sciences to Chemicals & Materials.  He has a Ph.D. in Analytical Chemistry and Mass Spectrometry from Purdue University. 

• Pharmaceutical R&D Informatics

Mats Sundgren, PhD, MSc, is a renowned expert in Health Data Strategy for Industry and Academia. Following a 12-year tenure as global integration lead for Electronic Health Records (EHR) services at AstraZeneca, Mats’ new portfolio encompasses the roles of Senior Industry Scientific Director for the i~HD (European Institute for Innovation through Health Data); Executive Strategic Advisor for IgniteData, developer of a system-agnostic EHR-to-EDC solution for clinical trials; and board member of the new Centre of Health Governance, University of Gothenburg. With over 37 years in the pharma industry (Discovery, Development, Manufacturing, IT R&D, Patents, Clinical Science, Data Science & AI), Mats is at the forefront of industry technology innovation. Career highlights at AstraZeneca include co-ordination of the European Innovative Medicine Initiative (IMI) EHR4CR project, pioneering trustworthy scalable Federated EHR research platform services (paving the way for commercial platforms such as InSite, TriNetX, Flatiron, Clinarion, and DEEP6). He also spearheaded AstraZeneca’s health data eSource capability build program for clinical trials and co-led the EIT Health-sponsored EHR2EDC project with European hospitals along with Sanofi, Janssen, and ICON. Mats has authored over 70 publications, books, and patents in Science and Economics (Health Data Science, Clinical Science, Medical Informatics, Business Modelling, Innovation & Creativity Management, and Device development.

• Bio-IT World: Venture, Innovation & Partnering

No bio available.

• Bioinformatics

Healthcare Executive with a record of accomplishment leading business development and growth at Fortune 500 companies and entrepreneurial success through three acquisitions, including M*Modal by 3M for $1.1B. Visionary Innovator motivated by developing strategies and delivering industry-first products that enable clinical efficiencies and improve patient care within the healthcare arena. Product Expert with recognized ability in creating and maintaining partnerships with large tech companies, and healthcare systems across every market. Driven Leader known for developing and empowering high-performing, autonomous teams that consistently exceed objectives and expectations.

• Bio-IT World: Venture, Innovation & Partnering

Iman Tavassoly, MD, PhD, is a highly experienced physician-scientist specializing in computational biology and quantitative medicine. With over 14 years of experience in the field, he has gained a reputation for his ability to apply cutting-edge quantitative techniques and technologies to advance healthcare research. His expertise in AI-based precision medicine and systems pharmacology has been instrumental in developing innovative solutions to the most pressing challenges in modern medicine. Currently serving as Senior Director at C2i Genomics, Dr. Tavassoly continues to make significant contributions to the field and is widely respected as an expert in precision medicine.

• Quantum Computing

Building production-grade, scalable Machine Learning pipelines that generate consistent and meaningful predictions for advancing effective and safe treatment options around the world.I assemble and build data products for Pharmaceutical industries, containing a human-in-the-loop algorithm (HILA) processed Sensor data with custom transformation. 2+ years of experience in developing healthcare Knowledge engineering solutions, data science, Python, predictive analytics, H20.ai, SQL, NoSQL, creating an asynchronous data pipeline and KOL management 8+ Years of Client Development, Alliance Management, and Subject Matter expertise in Healthcare Businesses, which lead to the cumulative business development of over $10Mn through various engagements.

• Cloud Computing

No bio available.

• Generative AI

Simon specializes in building software that is actually useable by scientists. Formerly an Assistant Professor working in the areas of Genomics and Biotechnology, he joined BioTeam in 2013. Since then, he has continued his focus on harnessing the cloud to build software tools for scientists while also embracing the power of DevOps to create the dynamic computing architectures needed for modern informatics. Simon has a Ph.D. in Biochemistry from the University of Nottingham in the UK and worked on Ubiquitin and related proteins for his postdoctoral work at the Medical College of Wisconsin in Milwaukee. His growing interest in software development led him into bioinformatics and he joined Prof. Howard Jacob’s group at the Medical College developing software for genomic mapping projects and became a faculty member in 2001. His research focused around genomics and genome databases. He was a principle investigator on a number of prominent bioinformatic projects-the Generic Model Organism Database (GMOD), the Rat Genome Database, the Gene Ontology Consortium, the National Center for Biomedical Ontology-along with directing the bioinformatics components for the MCW NHLBI National Proteomics Center and the MCW Center of Excellence in Genomics Science. His research group focused on promoting emerging software development tools such as Ruby on Rails and cloud computing and his group published the first example of a cloud-based analysis platform for proteomics in 2009. For three years prior to leaving MCW in 2011, he was the Biomedical Informatics Key Function Director for the MCW’s CTSA center, the South Eastern Wisconsin Clinical and Translational Science Institute.

• W2: Data Science in Practice: Embracing the Challenges, Unleashing the Possibilities

Dan joined Figshare in early 2014 as its first US-based employee. In his current role, he focuses on the development of Figshare in the US government and nonprofit, researcher, and biopharmaceutical communities though building strategic partnerships, community engagement, and educational outreach. Dan helps provide a lateral perspective across the research data management landscape in assessing the needs of researchers, academic publishers, and institutions alike, while also offering guidance on current industry trends.?In his previous roles, Dan held a number of positions in editorial, trade publishing, and licensing at one of the largest open access STEM publishers.

• FAIR Data

Simon is a Biological Sciences graduate from Birmingham University in the UK with over 25 years of commercial leadership experience in a variety of scientific software companies. Before joining Basepair as Chief Commercial Officer, Simon led the global enterprise informatics sales team at Illumina and also served as the VP of North America Sales at Seven Bridges Genomics.

• Cloud Computing

Brandon Varela is not only a scientist with a background in genomics and bioinformatics, but he also has over a decade of expertise in scientific data analysis. As a Principal Scientific Software Products at L7 Informatics, he brings nearly 6 years of hands-on experience in software product development. Brandon leverages his scientific and programming background to translate customers' needs into creative content solutions, software features and new applications.

• Data Management

Vas leads the customer team for Globus, an innovative software-as-a-service for research data management, developed and operated by the University of Chicago. He works with current and prospective users to grow adoption of the service and make it self-sustaining. Vas is also a lecturer in the Master's Program in Computer Science, where he teaches courses on Cloud Computing and Product Management. Vas has 30 years of experience in operational and consulting roles, spanning strategy, marketing, and technology. He has nurtured early-stage companies into successful businesses and consulted with companies on a wide range of strategic issues. Vas holds an MBA from the Ross School of Business at the University of Michigan, Ann Arbor, and a BS in Electrical Engineering from the University of the Witwatersrand in South Africa.

• Cloud Computing
• W8: Instrument-Driven Discovery for the 99%: Modern Infrastructure for Research

Mariano Vázquez, Ph.D. MV is co-founder and CTO / CSO of ELEM Biotech and researcher at the Barcelona Supercomputing Center (BSC). ELEM, a spinoff company of the BSC, was born to speeding up the technology transfer from BSC to the biomedical sector, by creating a supercomputer-based and cloud-deployed platform to perform in-silico clinical trials on massive populations of Virtual Humans. Virtual Humans are "avatars", a combination of sophisticate mathematical and computational modelling, and data, designed to predict the outcome of different therapies. Powered by BSC, our team develops tools which allows to study the cardiovascular and respiratory systems, with customers in both the medical devices sector and pharmaceutical industry. Infarction, ageing, damaged cardiac valves, arrhythmias, stent design or respiratory drug delivery are among the topics where such a tool can become a decisive help.

• AI for Drug Discovery and Development
• Generative AI
• AI for Oncology, Precision Medicine, and Health
• Bioinformatics
• W6: Biomedical Digital Twins
• Pharmaceutical R&D Informatics

AVP of Sales - Americas Enterprise

Neil leads the Enterprise Sales team for the Americas region, based in the Herndon. His team is dedicated to finding the ideal network technology and infrastructure solutions for enterprise customers.

With over 20 years of experience in international operations, sales support and business development. Neil has worked with a wide range of technologies throughout his career. These include data telecom, UCaaS, NaaS, and IoT services.

• Modern Data Platforms and Storage Infrastructure

Dr. Jo Viney, Ph.D., is Cofounder, President and CEO of Seismic Therapeutic, the machine learning immunology company developing medicines for autoimmune disease. A seasoned biotech executive and entrepreneurial scientist, she has co-founded 3 biotech startup companies in MA - the first of which, Pandion Therapeutics, was acquired by Merck in 2021 for $1.85B. Prior to Pandion she held research leadership positions and contributed to the drug discovery pipelines at Biogen, Amgen, and Immunex. She is an experienced director on both private and public company boards. Jo is a big advocate for workplace inclusiveness and regularly volunteers her time with a number of organizations focused on increasing diversity.

• Bio-IT World: Venture, Innovation & Partnering

I graduated from Towson University where I studied Biochemistry, Bioinformatics, and Molecular Biology. Shortly after completing my degree, I worked for the Moncla Laboratory at the University of Pennsylvania as a Research Specialist. The Moncla Laboratory is a leading computational virology research team interested in viral evolution especially related to highly pathogenic avian influenza virus, mumps virus, and SARS-CoV-2. The team models disease transmission patterns to disseminate complex host switching mechanisms. We relied on methods from phylodynamics, virology, and population genetics to understand how viruses evolve within individuals, between populations, and across continents. After leaving the University of Pennsylvania, I joined AstraZeneca as a Technology Advisor where I am currently working to research emerging technologies across the technology landscape.

• Quantum Computing

Manu Vohra is the Global lead for Life Sciences and Go-To-Market strategy for Cloud Content Management at Box.com. After two decades deploying ECM solutions in a regulated industry, he's spending his efforts supporting Life Sciences companies to ride the Digital Transformation wave and fully leverage the micro content service offerings of a modern Content Platform at Box.

• Software Applications and Services

Christina Vorvis, PhD is a Director of Venture Capital at AbbVie, where she leads investments in early-stage companies developing transformative therapies and technologies for cancer, immunology, neuroscience, eye care, and aesthetics based in Cambridge, Massachusetts. Christina has over 10 years of experience in the Life Sciences, including bench-side research, digital health, investment banking, and deal origination and deal execution at global institutions like Amgen, OrbiMed, and Back Bay Life Science Advisors. She earned her PhD in Cancer Biology from the University of California, Los Angeles where she studied the molecular mechanisms of tumor growth and progression in pancreatic cancer. Prior to joining AbbVie, Christina advised biotech and pharmaceutical companies on mergers and acquisitions, financings, and other strategic transactions. Dr. Vorvis is currently a Board Observer for Kojin Tx and Accent Therapeutics.

• Bio-IT World: Venture, Innovation & Partnering

Dr. Walsh is an experienced enzyme kineticist, with experience in aptamer and biosensor development.

• Data Science and Analytics Technologies

Monica currently leads the Biology (including Biologics) Capabilities and Products in Takeda Scientific Informatics. She comes with multidiscipline education with PhD in Biochemistry and MSc in Software Engineering. She has 8+ years of experience in academic research and 15+ years of experience in Research Informatics in the biotechnology and pharmaceutical industries. She is good at strategic planning with proven successful track records of managing complicated global enterprise informatics projects. She has delivered many informatics projects/programs within time and budget for many departments (Global Biologics, Molecular Pathology, Protein Science, Biotherapeutics, Translational Medicine, and Legal IP, et al). She is technically and scientifically proficient in Bioinformatics, Cheminformatics, Functional Genomics, and Pharmacogenomics. Her team has designed and implemented many global enterprise informatics solutions to support biologics research, biomarker discovery, translational research, and personalized medicine. Her recent focus is concentrated on building a state-of-art Global Biologics Platform to support the global biologics R&D research in Oncology, GI, and CNS across Takeda.

• Digital Biopharma